Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Pharmacology and Experimental Therapeutics
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Journal of Pharmacology and Experimental Therapeutics

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit jpet on Facebook
  • Follow jpet on Twitter
  • Follow jpet on LinkedIn

Index by author

August 01, 1996; Volume 278,Issue 2
  • A
  • B
  • C
  • D
  • E
  • F
  • G
  • H
  • I
  • J
  • K
  • L
  • M
  • N
  • O
  • P
  • Q
  • R
  • S
  • T
  • U
  • V
  • W
  • X
  • Y
  • Z

A

  1. Abe, M

    1. You have access
      Novel benzodioxan derivative, 5-[3-[((2S)-1,4-benzodioxan-2-ylmethyl) amino]propoxy]-1,3-benzodioxole HCl (MKC-242), with anxiolytic-like and antidepressant-like effects in animal models.
      M Abe, R Tabata, K Saito, T Matsuda, A Baba and M Egawa
      Journal of Pharmacology and Experimental Therapeutics August 1996, 278 (2) 898-905;
  2. Adam, A

    1. You have access
      Chloramphenicol and the inflammatory response in the rat. Upregulation of the gene for T2-kininogen in liver.
      P Raymond, H Wang, C Blais, A Décarie, A Adam and R Morais
      Journal of Pharmacology and Experimental Therapeutics August 1996, 278 (2) 934-940;
  3. Agrawal, S

    1. You have access
      Pharmacokinetics and tissue disposition of a chimeric oligodeoxynucleoside phosphorothioate in rats after intravenous administration.
      R Zhang, R P Iyer, D Yu, W Tan, X Zhang, Z Lu, H Zhao and S Agrawal
      Journal of Pharmacology and Experimental Therapeutics August 1996, 278 (2) 971-979;
  4. Aigner, T G

    1. You have access
      D-cycloserine, a partial agonist at the glycine site coupled to N-methyl-D-aspartate receptors, improves visual recognition memory in rhesus monkeys.
      N Matsuoka and T G Aigner
      Journal of Pharmacology and Experimental Therapeutics August 1996, 278 (2) 891-897;
  5. Ali, S

    1. You have access
      Simultaneous measurement of cyclopentyladenosine-induced contraction and intracellular calcium in bronchial rings from allergic rabbits and it's antagonism.
      S Ali, W J Metzger and S J Mustafa
      Journal of Pharmacology and Experimental Therapeutics August 1996, 278 (2) 639-644;
  6. Almström, S

    1. You have access
      A comparison of the effects of glial cell line-derived neurotrophic factor on spinal cord and cortex cerebri grafts.
      K Trok, S Almström and L Olson
      Journal of Pharmacology and Experimental Therapeutics August 1996, 278 (2) 941-949;
  7. Anyukhovsky, E P

    1. You have access
      Chronic in vivo and in vitro effects of amiodarone on guinea pig hearts.
      E A Sosunov, E P Anyukhovsky and M R Rosen
      Journal of Pharmacology and Experimental Therapeutics August 1996, 278 (2) 906-912;
  8. Apparsundaram, S

    1. You have access
      Prejunctional alpha adrenoceptor desensitization in rat heart after chronic epinephrine treatment.
      S Apparsundaram and D C Eikenburg
      Journal of Pharmacology and Experimental Therapeutics August 1996, 278 (2) 862-870;
  9. Aquino, R

    1. You have access
      Differential effects of muscarinic receptor agonists and phorbol ester on muscarinic and D2-dopamine release-modulatory receptors.
      I S Hoffmann, R K Talmaciu, R Aquino and L X Cubeddu
      Journal of Pharmacology and Experimental Therapeutics August 1996, 278 (2) 662-668;
  10. Arai, A

    1. You have access
      Effects of a memory-enhancing drug on DL-alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor currents and synaptic transmission in hippocampus.
      A Arai, M Kessler, G Rogers and G Lynch
      Journal of Pharmacology and Experimental Therapeutics August 1996, 278 (2) 627-638;
  11. Arnar, D O

    1. You have access
      Mechanism of alpha-2 adrenergic modulation of canine cardiac Purkinje action potential.
      H C Lee, J J Cai, D O Arnar, E F Shibata and J B Martins
      Journal of Pharmacology and Experimental Therapeutics August 1996, 278 (2) 597-606;
  12. Arnold, L W

    1. You have access
      Antiphencyclidine monoclonal Fab fragments reverse phencyclidine-induced behavioral effects and ataxia in rats.
      J L Valentine, M Mayersohn, W D Wessinger, L W Arnold and S M Owens
      Journal of Pharmacology and Experimental Therapeutics August 1996, 278 (2) 709-716;
  13. Atsuki, K

    1. You have access
      Effects of ONO-1101, a novel beta-antagonist, on action potential and membrane currents in cardiac muscle.
      K Muraki, H Nakagawa, N Nagano, S Henmi, H Kawasumi, T Nakanishi, K Imaizumi, T Tokuno, K Atsuki, Y Imaizumi and M Watanabe
      Journal of Pharmacology and Experimental Therapeutics August 1996, 278 (2) 555-563;

B

  1. Baba, A

    1. You have access
      Novel benzodioxan derivative, 5-[3-[((2S)-1,4-benzodioxan-2-ylmethyl) amino]propoxy]-1,3-benzodioxole HCl (MKC-242), with anxiolytic-like and antidepressant-like effects in animal models.
      M Abe, R Tabata, K Saito, T Matsuda, A Baba and M Egawa
      Journal of Pharmacology and Experimental Therapeutics August 1996, 278 (2) 898-905;
  2. Barth, F

    1. You have access
      Characterization of two cloned human CB1 cannabinoid receptor isoforms.
      M Rinaldi-Carmona, B Calandra, D Shire, M Bouaboula, D Oustric, F Barth, P Casellas, P Ferrara and G Le Fur
      Journal of Pharmacology and Experimental Therapeutics August 1996, 278 (2) 871-878;
  3. Bauer, J

    1. You have access
      Immunomodulator OM 163-induced reversal of tumor-mediated immunosuppression and downregulation of TGF-beta 1 in vivo.
      P Lagadec, S Reveneau, P Lejeune, D Pinard, T Borman, J Bauer and J F Jeannin
      Journal of Pharmacology and Experimental Therapeutics August 1996, 278 (2) 926-933;
  4. Behan, D P

    1. You have access
      Regulation of corticotropin-releasing factor-binding protein expression in cultured rat astrocytes.
      D Maciejewski, P D Crowe, E B De Souza and D P Behan
      Journal of Pharmacology and Experimental Therapeutics August 1996, 278 (2) 455-461;
  5. Bellin, S

    1. You have access
      Mechanisms of plumbagin action on guinea pig isolated atria.
      M Floreani, A Forlin, L Pandolfo, M Petrone and S Bellin
      Journal of Pharmacology and Experimental Therapeutics August 1996, 278 (2) 763-770;
  6. Berger, M E

    1. You have access
      Platelet lipoxygenase inhibitors attenuate thrombin- and thromboxane mimetic-induced intracellular calcium mobilization and platelet aggregation.
      M D Nyby, M Sasaki, Y Ideguchi, H E Wynne, M T Hori, M E Berger, M S Golub, A S Brickman and M L Tuck
      Journal of Pharmacology and Experimental Therapeutics August 1996, 278 (2) 503-509;
  7. Beslot, F

    1. You have access
      Inhibition of both angiotensin-converting enzyme and neutral endopeptidase by S21402 (RB105) in rats with experimental myocardial infarction.
      W Gonzalez, F Beslot, I Laboulandine, M C Fournié-Zaluski, B P Roques and J B Michel
      Journal of Pharmacology and Experimental Therapeutics August 1996, 278 (2) 573-581;
  8. Bigelow, G E

    1. You have access
      Buprenorphine, morphine and naloxone effects during ascending morphine maintenance in humans.
      K J Schuh, S L Walsh, G E Bigelow, K L Preston and M L Stitzer
      Journal of Pharmacology and Experimental Therapeutics August 1996, 278 (2) 836-846;
  9. Blais, C

    1. You have access
      Chloramphenicol and the inflammatory response in the rat. Upregulation of the gene for T2-kininogen in liver.
      P Raymond, H Wang, C Blais, A Décarie, A Adam and R Morais
      Journal of Pharmacology and Experimental Therapeutics August 1996, 278 (2) 934-940;
  10. Bonanno, G

    1. You have access
      Human brain cholecystokinin: release of cholecystokinin-like immunoreactivity (CCK-LI) from isolated cortical nerve endings and its modulation through GABA(B) receptors.
      M Raiteri, G Bonanno, P Paudice, P Cavazzani and G Schmid
      Journal of Pharmacology and Experimental Therapeutics August 1996, 278 (2) 747-751;
  11. Borman, T

    1. You have access
      Immunomodulator OM 163-induced reversal of tumor-mediated immunosuppression and downregulation of TGF-beta 1 in vivo.
      P Lagadec, S Reveneau, P Lejeune, D Pinard, T Borman, J Bauer and J F Jeannin
      Journal of Pharmacology and Experimental Therapeutics August 1996, 278 (2) 926-933;
  12. Born, S L

    1. You have access
      Escherichia coli expression and substrate specificities of canine cytochrome P450 3A12 and rabbit cytochrome P450 3A6.
      S L Born, D J Fraser, G R Harlow and J R Halpert
      Journal of Pharmacology and Experimental Therapeutics August 1996, 278 (2) 957-963;
  13. Bouaboula, M

    1. You have access
      Characterization of two cloned human CB1 cannabinoid receptor isoforms.
      M Rinaldi-Carmona, B Calandra, D Shire, M Bouaboula, D Oustric, F Barth, P Casellas, P Ferrara and G Le Fur
      Journal of Pharmacology and Experimental Therapeutics August 1996, 278 (2) 871-878;
  14. Brickman, A S

    1. You have access
      Platelet lipoxygenase inhibitors attenuate thrombin- and thromboxane mimetic-induced intracellular calcium mobilization and platelet aggregation.
      M D Nyby, M Sasaki, Y Ideguchi, H E Wynne, M T Hori, M E Berger, M S Golub, A S Brickman and M L Tuck
      Journal of Pharmacology and Experimental Therapeutics August 1996, 278 (2) 503-509;
  15. Brougham, L R

    1. You have access
      Ex vivo studies with iloperidone (HP 873), a potential atypical antipsychotic with dopamine D2/5-hydroxytryptamine2 receptor antagonist activity.
      A M Szczepanik, L R Brougham, J E Roehr, P G Conway, D B Ellis and C A Wilmot
      Journal of Pharmacology and Experimental Therapeutics August 1996, 278 (2) 913-920;

C

  1. Cai, J J

    1. You have access
      Mechanism of alpha-2 adrenergic modulation of canine cardiac Purkinje action potential.
      H C Lee, J J Cai, D O Arnar, E F Shibata and J B Martins
      Journal of Pharmacology and Experimental Therapeutics August 1996, 278 (2) 597-606;
  2. Calandra, B

    1. You have access
      Characterization of two cloned human CB1 cannabinoid receptor isoforms.
      M Rinaldi-Carmona, B Calandra, D Shire, M Bouaboula, D Oustric, F Barth, P Casellas, P Ferrara and G Le Fur
      Journal of Pharmacology and Experimental Therapeutics August 1996, 278 (2) 871-878;
  3. Canning, B J

    1. You have access
      Inhibition by zinc protoporphyrin-IX of vasoactive intestinal peptide-induced relaxations of guinea pig isolated trachea.
      B J Undem, J L Ellis, S Meeker, A Fischer and B J Canning
      Journal of Pharmacology and Experimental Therapeutics August 1996, 278 (2) 964-970;
  4. Carr, D J

    1. You have access
      Morphine suppresses the alloantigen-driven CTL response in a dose-dependent and naltrexone reversible manner.
      M Scott and D J Carr
      Journal of Pharmacology and Experimental Therapeutics August 1996, 278 (2) 980-988;
  5. Casellas, P

    1. You have access
      Characterization of two cloned human CB1 cannabinoid receptor isoforms.
      M Rinaldi-Carmona, B Calandra, D Shire, M Bouaboula, D Oustric, F Barth, P Casellas, P Ferrara and G Le Fur
      Journal of Pharmacology and Experimental Therapeutics August 1996, 278 (2) 871-878;
  6. Catania, V A

    1. You have access
      Ovine prolactin increases hepatic UDP-glucuronosyltransferase activity in ovariectomized rats.
      M G Luquita, V A Catania, E J Sánchez-Pozzi and A D Mottino
      Journal of Pharmacology and Experimental Therapeutics August 1996, 278 (2) 921-925;
  7. Cavazzani, P

    1. You have access
      Human brain cholecystokinin: release of cholecystokinin-like immunoreactivity (CCK-LI) from isolated cortical nerve endings and its modulation through GABA(B) receptors.
      M Raiteri, G Bonanno, P Paudice, P Cavazzani and G Schmid
      Journal of Pharmacology and Experimental Therapeutics August 1996, 278 (2) 747-751;
  8. Chang, S P

    1. You have access
      Vascular hyporesponsiveness in aorta from portal hypertensive rats: possible sites of involvement.
      Y T Huang, G F Wang, M C Yang, S P Chang, H C Lin and C Y Hong
      Journal of Pharmacology and Experimental Therapeutics August 1996, 278 (2) 535-541;
  9. Chavez-Noriega, L

    1. You have access
      Cloning and functional characterization of human heteromeric N-methyl-D-aspartate receptors.
      S D Hess, L P Daggett, J Crona, C Deal, C C Lu, A Urrutia, L Chavez-Noriega, S B Ellis, E C Johnson and G Veliçelebi
      Journal of Pharmacology and Experimental Therapeutics August 1996, 278 (2) 808-816;
  10. Chiu, T

    1. You have access
      Role of cyclic GMP-inhibitable phosphodiesterase and nitric oxide in the beta adrenoceptor control of renin secretion.
      T Chiu and I A Reid
      Journal of Pharmacology and Experimental Therapeutics August 1996, 278 (2) 793-799;
  11. Conway, P G

    1. You have access
      Ex vivo studies with iloperidone (HP 873), a potential atypical antipsychotic with dopamine D2/5-hydroxytryptamine2 receptor antagonist activity.
      A M Szczepanik, L R Brougham, J E Roehr, P G Conway, D B Ellis and C A Wilmot
      Journal of Pharmacology and Experimental Therapeutics August 1996, 278 (2) 913-920;
  12. Corradetti, R

    1. You have access
      Electrophysiological effects of N-(2-(4-(2-methoxyphenyl)-1-piperazinyl)ethyl)-N-(2-pyridinyl) cyclohexane carboxamide (WAY 100635) on dorsal raphe serotonergic neurons and CA1 hippocampal pyramidal cells in vitro.
      R Corradetti, E Le Poul, N Laaris, M Hamon and L Lanfumey
      Journal of Pharmacology and Experimental Therapeutics August 1996, 278 (2) 679-688;
  13. Crona, J

    1. You have access
      Cloning and functional characterization of human heteromeric N-methyl-D-aspartate receptors.
      S D Hess, L P Daggett, J Crona, C Deal, C C Lu, A Urrutia, L Chavez-Noriega, S B Ellis, E C Johnson and G Veliçelebi
      Journal of Pharmacology and Experimental Therapeutics August 1996, 278 (2) 808-816;
  14. Crowe, P D

    1. You have access
      Regulation of corticotropin-releasing factor-binding protein expression in cultured rat astrocytes.
      D Maciejewski, P D Crowe, E B De Souza and D P Behan
      Journal of Pharmacology and Experimental Therapeutics August 1996, 278 (2) 455-461;
  15. Cubeddu, L X

    1. You have access
      Differential effects of muscarinic receptor agonists and phorbol ester on muscarinic and D2-dopamine release-modulatory receptors.
      I S Hoffmann, R K Talmaciu, R Aquino and L X Cubeddu
      Journal of Pharmacology and Experimental Therapeutics August 1996, 278 (2) 662-668;

D

  1. Daggett, L P

    1. You have access
      Cloning and functional characterization of human heteromeric N-methyl-D-aspartate receptors.
      S D Hess, L P Daggett, J Crona, C Deal, C C Lu, A Urrutia, L Chavez-Noriega, S B Ellis, E C Johnson and G Veliçelebi
      Journal of Pharmacology and Experimental Therapeutics August 1996, 278 (2) 808-816;
  2. Deal, C

    1. You have access
      Cloning and functional characterization of human heteromeric N-methyl-D-aspartate receptors.
      S D Hess, L P Daggett, J Crona, C Deal, C C Lu, A Urrutia, L Chavez-Noriega, S B Ellis, E C Johnson and G Veliçelebi
      Journal of Pharmacology and Experimental Therapeutics August 1996, 278 (2) 808-816;
  3. Décarie, A

    1. You have access
      Chloramphenicol and the inflammatory response in the rat. Upregulation of the gene for T2-kininogen in liver.
      P Raymond, H Wang, C Blais, A Décarie, A Adam and R Morais
      Journal of Pharmacology and Experimental Therapeutics August 1996, 278 (2) 934-940;
  4. Deplanne, V

    1. You have access
      Functional characterization of alpha-1-adrenoceptor subtypes in the prostatic urethra and trigone of male rabbit.
      V Deplanne and A M Galzin
      Journal of Pharmacology and Experimental Therapeutics August 1996, 278 (2) 527-534;
  5. De Souza, E B

    1. You have access
      Regulation of corticotropin-releasing factor-binding protein expression in cultured rat astrocytes.
      D Maciejewski, P D Crowe, E B De Souza and D P Behan
      Journal of Pharmacology and Experimental Therapeutics August 1996, 278 (2) 455-461;
  6. Devaud, L L

    1. You have access
      Sensitization of gamma-aminobutyric acidA receptors to neuroactive steroids in rats during ethanol withdrawal.
      L L Devaud, R H Purdy, D A Finn and A L Morrow
      Journal of Pharmacology and Experimental Therapeutics August 1996, 278 (2) 510-517;
  7. Diao, L

    1. You have access
      Interactions between ethanol, endogenous adenosine and adenosine uptake in hippocampal brain slices.
      L Diao and T V Dunwiddie
      Journal of Pharmacology and Experimental Therapeutics August 1996, 278 (2) 542-546;
  8. Dingledine, R

    1. You have access
      Block of alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptors by polyamines and polyamine toxins.
      M S Washburn and R Dingledine
      Journal of Pharmacology and Experimental Therapeutics August 1996, 278 (2) 669-678;
  9. Dunnick, C A

    1. You have access
      Mechanism mediating basolateral transport of 2,4-dichlorophenoxyacetic acid in rat kidney.
      A R Villalobos, C A Dunnick and J B Pritchard
      Journal of Pharmacology and Experimental Therapeutics August 1996, 278 (2) 582-589;
  10. Dunwiddie, T V

    1. You have access
      Interactions between ethanol, endogenous adenosine and adenosine uptake in hippocampal brain slices.
      L Diao and T V Dunwiddie
      Journal of Pharmacology and Experimental Therapeutics August 1996, 278 (2) 542-546;

E

  1. Egawa, M

    1. You have access
      Novel benzodioxan derivative, 5-[3-[((2S)-1,4-benzodioxan-2-ylmethyl) amino]propoxy]-1,3-benzodioxole HCl (MKC-242), with anxiolytic-like and antidepressant-like effects in animal models.
      M Abe, R Tabata, K Saito, T Matsuda, A Baba and M Egawa
      Journal of Pharmacology and Experimental Therapeutics August 1996, 278 (2) 898-905;
  2. Eikenburg, D C

    1. You have access
      Prejunctional alpha adrenoceptor desensitization in rat heart after chronic epinephrine treatment.
      S Apparsundaram and D C Eikenburg
      Journal of Pharmacology and Experimental Therapeutics August 1996, 278 (2) 862-870;
  3. Ellis, D B

    1. You have access
      Ex vivo studies with iloperidone (HP 873), a potential atypical antipsychotic with dopamine D2/5-hydroxytryptamine2 receptor antagonist activity.
      A M Szczepanik, L R Brougham, J E Roehr, P G Conway, D B Ellis and C A Wilmot
      Journal of Pharmacology and Experimental Therapeutics August 1996, 278 (2) 913-920;
  4. Ellis, J L

    1. You have access
      Inhibition by zinc protoporphyrin-IX of vasoactive intestinal peptide-induced relaxations of guinea pig isolated trachea.
      B J Undem, J L Ellis, S Meeker, A Fischer and B J Canning
      Journal of Pharmacology and Experimental Therapeutics August 1996, 278 (2) 964-970;
  5. Ellis, S B

    1. You have access
      Cloning and functional characterization of human heteromeric N-methyl-D-aspartate receptors.
      S D Hess, L P Daggett, J Crona, C Deal, C C Lu, A Urrutia, L Chavez-Noriega, S B Ellis, E C Johnson and G Veliçelebi
      Journal of Pharmacology and Experimental Therapeutics August 1996, 278 (2) 808-816;

F

  1. Feinmark, S J

    1. You have access
      Phospholipase D activity regulates the binding of leukotriene B4 to human polymorphonuclear leukocytes.
      D Kiel and S J Feinmark
      Journal of Pharmacology and Experimental Therapeutics August 1996, 278 (2) 645-653;
  2. Feng, Z

    1. You have access
      Leukotriene B4 modulates in vivo expression of delayed-type hypersensitivity by a receptor-mediated mechanism: regulation by lipoxin A4.
      Z Feng, H P Godfrey, S Mandy, S Strudwick, K T Lin, E Heilman and P Y Wong
      Journal of Pharmacology and Experimental Therapeutics August 1996, 278 (2) 950-956;
  3. Ferrara, P

    1. You have access
      Characterization of two cloned human CB1 cannabinoid receptor isoforms.
      M Rinaldi-Carmona, B Calandra, D Shire, M Bouaboula, D Oustric, F Barth, P Casellas, P Ferrara and G Le Fur
      Journal of Pharmacology and Experimental Therapeutics August 1996, 278 (2) 871-878;
  4. Feurle, G E

    1. You have access
      Neurokinetic and myokinetic effects of the peptide xenin on the motility of the small and large intestine of guinea pig.
      G E Feurle, A Klein, G Hamscher, J W Metzger and J A Schuurkes
      Journal of Pharmacology and Experimental Therapeutics August 1996, 278 (2) 654-661;
  5. Finn, D A

    1. You have access
      Sensitization of gamma-aminobutyric acidA receptors to neuroactive steroids in rats during ethanol withdrawal.
      L L Devaud, R H Purdy, D A Finn and A L Morrow
      Journal of Pharmacology and Experimental Therapeutics August 1996, 278 (2) 510-517;
  6. Fischer, A

    1. You have access
      Inhibition by zinc protoporphyrin-IX of vasoactive intestinal peptide-induced relaxations of guinea pig isolated trachea.
      B J Undem, J L Ellis, S Meeker, A Fischer and B J Canning
      Journal of Pharmacology and Experimental Therapeutics August 1996, 278 (2) 964-970;
  7. Fleshner, M R

    1. You have access
      Morphine-induced alterations in antibody levels: receptor and immune mechanisms.
      L L Lockwood, L H Silbert, M R Fleshner, C McNeal, L R Watkins, M L Laudenslager, K C Rice, R J Weber and S F Maier
      Journal of Pharmacology and Experimental Therapeutics August 1996, 278 (2) 689-696;
  8. Floreani, M

    1. You have access
      Mechanisms of plumbagin action on guinea pig isolated atria.
      M Floreani, A Forlin, L Pandolfo, M Petrone and S Bellin
      Journal of Pharmacology and Experimental Therapeutics August 1996, 278 (2) 763-770;
  9. Forlin, A

    1. You have access
      Mechanisms of plumbagin action on guinea pig isolated atria.
      M Floreani, A Forlin, L Pandolfo, M Petrone and S Bellin
      Journal of Pharmacology and Experimental Therapeutics August 1996, 278 (2) 763-770;
  10. Fornal, C A

    1. You have access
      WAY-100635, a potent and selective 5-hydroxytryptamine1A antagonist, increases serotonergic neuronal activity in behaving cats: comparison with (S)-WAY-100135.
      C A Fornal, C W Metzler, R A Gallegos, S C Veasey, A C McCreary and B L Jacobs
      Journal of Pharmacology and Experimental Therapeutics August 1996, 278 (2) 752-762;
  11. Fournié-Zaluski, M C

    1. You have access
      Inhibition of both angiotensin-converting enzyme and neutral endopeptidase by S21402 (RB105) in rats with experimental myocardial infarction.
      W Gonzalez, F Beslot, I Laboulandine, M C Fournié-Zaluski, B P Roques and J B Michel
      Journal of Pharmacology and Experimental Therapeutics August 1996, 278 (2) 573-581;
  12. Fraser, D J

    1. You have access
      Escherichia coli expression and substrate specificities of canine cytochrome P450 3A12 and rabbit cytochrome P450 3A6.
      S L Born, D J Fraser, G R Harlow and J R Halpert
      Journal of Pharmacology and Experimental Therapeutics August 1996, 278 (2) 957-963;
  13. Fuh, S M

    1. You have access
      Locally application of amphetamine into the ventral tegmental area enhances dopamine release in the nucleus accumbens and the medial prefrontal cortex through noradrenergic neurotransmission.
      W H Pan, J C Sung and S M Fuh
      Journal of Pharmacology and Experimental Therapeutics August 1996, 278 (2) 725-731;
  14. Fukami, T

    1. You have access
      Carrier-mediated active transport of BQ-123, a peptidic endothelin antagonist, into rat hepatocytes.
      T Nakamura, A Hisaka, Y Sawasaki, Y Suzuki, T Fukami, K Ishikawa, M Yano and Y Sugiyama
      Journal of Pharmacology and Experimental Therapeutics August 1996, 278 (2) 564-572;
  15. Fulton, D

    1. You have access
      Role of phospholipase C and phospholipase A2 in the nitric oxide-independent vasodilator effect of bradykinin in the rat perfused heart.
      D Fulton, J C McGiff and J Quilley
      Journal of Pharmacology and Experimental Therapeutics August 1996, 278 (2) 518-526;

G

  1. Gallegos, R A

    1. You have access
      WAY-100635, a potent and selective 5-hydroxytryptamine1A antagonist, increases serotonergic neuronal activity in behaving cats: comparison with (S)-WAY-100135.
      C A Fornal, C W Metzler, R A Gallegos, S C Veasey, A C McCreary and B L Jacobs
      Journal of Pharmacology and Experimental Therapeutics August 1996, 278 (2) 752-762;
  2. Gálvez, J

    1. You have access
      Effect of quercitrin on acute and chronic experimental colitis in the rat.
      F Sánchez de Medina, J Gálvez, J A Romero and A Zarzuelo
      Journal of Pharmacology and Experimental Therapeutics August 1996, 278 (2) 771-779;
  3. Galzin, A M

    1. You have access
      Functional characterization of alpha-1-adrenoceptor subtypes in the prostatic urethra and trigone of male rabbit.
      V Deplanne and A M Galzin
      Journal of Pharmacology and Experimental Therapeutics August 1996, 278 (2) 527-534;
  4. Gater, P R

    1. You have access
      Pharmacological evidence for tumor necrosis factor as a mediator of allergic inflammation in the airways.
      L M Renzetti, P M Paciorek, S A Tannu, N C Rinaldi, J E Tocker, M A Wasserman and P R Gater
      Journal of Pharmacology and Experimental Therapeutics August 1996, 278 (2) 847-853;
  5. Gent, J P

    1. You have access
      gamma-Aminobutyric acidA receptors and spinally mediated antinociception in rats.
      R Nadeson, Z Guo, V Porter, J P Gent and C S Goodchild
      Journal of Pharmacology and Experimental Therapeutics August 1996, 278 (2) 620-626;
  6. Gerthoffer, W T

    1. You have access
      Agonist synergism in airway smooth muscle contraction.
      W T Gerthoffer
      Journal of Pharmacology and Experimental Therapeutics August 1996, 278 (2) 800-807;
  7. Gibb, J W

    1. You have access
      Microdialysis assessment of methamphetamine-induced changes in extracellular neurotensin in the striatum and nucleus accumbens.
      J D Wagstaff, J W Gibb and G R Hanson
      Journal of Pharmacology and Experimental Therapeutics August 1996, 278 (2) 547-554;
  8. Godfrey, H P

    1. You have access
      Leukotriene B4 modulates in vivo expression of delayed-type hypersensitivity by a receptor-mediated mechanism: regulation by lipoxin A4.
      Z Feng, H P Godfrey, S Mandy, S Strudwick, K T Lin, E Heilman and P Y Wong
      Journal of Pharmacology and Experimental Therapeutics August 1996, 278 (2) 950-956;
  9. Golub, M S

    1. You have access
      Platelet lipoxygenase inhibitors attenuate thrombin- and thromboxane mimetic-induced intracellular calcium mobilization and platelet aggregation.
      M D Nyby, M Sasaki, Y Ideguchi, H E Wynne, M T Hori, M E Berger, M S Golub, A S Brickman and M L Tuck
      Journal of Pharmacology and Experimental Therapeutics August 1996, 278 (2) 503-509;
  10. Gonzalez, W

    1. You have access
      Inhibition of both angiotensin-converting enzyme and neutral endopeptidase by S21402 (RB105) in rats with experimental myocardial infarction.
      W Gonzalez, F Beslot, I Laboulandine, M C Fournié-Zaluski, B P Roques and J B Michel
      Journal of Pharmacology and Experimental Therapeutics August 1996, 278 (2) 573-581;
  11. Goodchild, C S

    1. You have access
      gamma-Aminobutyric acidA receptors and spinally mediated antinociception in rats.
      R Nadeson, Z Guo, V Porter, J P Gent and C S Goodchild
      Journal of Pharmacology and Experimental Therapeutics August 1996, 278 (2) 620-626;
  12. Guo, Z

    1. You have access
      gamma-Aminobutyric acidA receptors and spinally mediated antinociception in rats.
      R Nadeson, Z Guo, V Porter, J P Gent and C S Goodchild
      Journal of Pharmacology and Experimental Therapeutics August 1996, 278 (2) 620-626;

H

  1. Halpert, J R

    1. You have access
      Escherichia coli expression and substrate specificities of canine cytochrome P450 3A12 and rabbit cytochrome P450 3A6.
      S L Born, D J Fraser, G R Harlow and J R Halpert
      Journal of Pharmacology and Experimental Therapeutics August 1996, 278 (2) 957-963;
  2. Hamon, M

    1. You have access
      Electrophysiological effects of N-(2-(4-(2-methoxyphenyl)-1-piperazinyl)ethyl)-N-(2-pyridinyl) cyclohexane carboxamide (WAY 100635) on dorsal raphe serotonergic neurons and CA1 hippocampal pyramidal cells in vitro.
      R Corradetti, E Le Poul, N Laaris, M Hamon and L Lanfumey
      Journal of Pharmacology and Experimental Therapeutics August 1996, 278 (2) 679-688;
  3. Hamscher, G

    1. You have access
      Neurokinetic and myokinetic effects of the peptide xenin on the motility of the small and large intestine of guinea pig.
      G E Feurle, A Klein, G Hamscher, J W Metzger and J A Schuurkes
      Journal of Pharmacology and Experimental Therapeutics August 1996, 278 (2) 654-661;
  4. Hanson, G R

    1. You have access
      Microdialysis assessment of methamphetamine-induced changes in extracellular neurotensin in the striatum and nucleus accumbens.
      J D Wagstaff, J W Gibb and G R Hanson
      Journal of Pharmacology and Experimental Therapeutics August 1996, 278 (2) 547-554;
  5. Harlow, G R

    1. You have access
      Escherichia coli expression and substrate specificities of canine cytochrome P450 3A12 and rabbit cytochrome P450 3A6.
      S L Born, D J Fraser, G R Harlow and J R Halpert
      Journal of Pharmacology and Experimental Therapeutics August 1996, 278 (2) 957-963;
  6. Heidbreder, C A

    1. You have access
      Role of extracellular dopamine in the initiation and long-term expression of behavioral sensitization to cocaine.
      C A Heidbreder, A C Thompson and T S Shippenberg
      Journal of Pharmacology and Experimental Therapeutics August 1996, 278 (2) 490-502;
  7. Heilman, E

    1. You have access
      Leukotriene B4 modulates in vivo expression of delayed-type hypersensitivity by a receptor-mediated mechanism: regulation by lipoxin A4.
      Z Feng, H P Godfrey, S Mandy, S Strudwick, K T Lin, E Heilman and P Y Wong
      Journal of Pharmacology and Experimental Therapeutics August 1996, 278 (2) 950-956;
  8. Henmi, S

    1. You have access
      Effects of ONO-1101, a novel beta-antagonist, on action potential and membrane currents in cardiac muscle.
      K Muraki, H Nakagawa, N Nagano, S Henmi, H Kawasumi, T Nakanishi, K Imaizumi, T Tokuno, K Atsuki, Y Imaizumi and M Watanabe
      Journal of Pharmacology and Experimental Therapeutics August 1996, 278 (2) 555-563;
  9. Hess, S D

    1. You have access
      Cloning and functional characterization of human heteromeric N-methyl-D-aspartate receptors.
      S D Hess, L P Daggett, J Crona, C Deal, C C Lu, A Urrutia, L Chavez-Noriega, S B Ellis, E C Johnson and G Veliçelebi
      Journal of Pharmacology and Experimental Therapeutics August 1996, 278 (2) 808-816;
  10. Hinz, V C

    1. You have access
      Effects of metrifonate, its transformation product dichlorvos, and other organophosphorus and reference cholinesterase inhibitors on Morris water escape behavior in young-adult rats.
      F J van der Staay, V C Hinz and B H Schmidt
      Journal of Pharmacology and Experimental Therapeutics August 1996, 278 (2) 697-708;
  11. Hisaka, A

    1. You have access
      Carrier-mediated active transport of BQ-123, a peptidic endothelin antagonist, into rat hepatocytes.
      T Nakamura, A Hisaka, Y Sawasaki, Y Suzuki, T Fukami, K Ishikawa, M Yano and Y Sugiyama
      Journal of Pharmacology and Experimental Therapeutics August 1996, 278 (2) 564-572;
    2. You have access
      The endothelin receptor is a major determinant for the nonlinear tissue distribution of the endothelin antagonist BQ-123.
      H C Shin, Y Kato, Y Shitara, T Yamada, T Nakamura, A Hisaka and Y Sugiyama
      Journal of Pharmacology and Experimental Therapeutics August 1996, 278 (2) 607-613;
  12. Hoffmann, I S

    1. You have access
      Differential effects of muscarinic receptor agonists and phorbol ester on muscarinic and D2-dopamine release-modulatory receptors.
      I S Hoffmann, R K Talmaciu, R Aquino and L X Cubeddu
      Journal of Pharmacology and Experimental Therapeutics August 1996, 278 (2) 662-668;
  13. Hong, C Y

    1. You have access
      Vascular hyporesponsiveness in aorta from portal hypertensive rats: possible sites of involvement.
      Y T Huang, G F Wang, M C Yang, S P Chang, H C Lin and C Y Hong
      Journal of Pharmacology and Experimental Therapeutics August 1996, 278 (2) 535-541;
  14. Hori, M

    1. You have access
      A nitric oxide donor reverses myocardial injury in rabbits with acute hypercholesterolemia.
      S Hoshida, N Yamashita, J Igarashi, M Nishida, M Hori, T Kuzuya and M Tada
      Journal of Pharmacology and Experimental Therapeutics August 1996, 278 (2) 741-746;
  15. Hori, M T

    1. You have access
      Platelet lipoxygenase inhibitors attenuate thrombin- and thromboxane mimetic-induced intracellular calcium mobilization and platelet aggregation.
      M D Nyby, M Sasaki, Y Ideguchi, H E Wynne, M T Hori, M E Berger, M S Golub, A S Brickman and M L Tuck
      Journal of Pharmacology and Experimental Therapeutics August 1996, 278 (2) 503-509;
  16. Hoshida, S

    1. You have access
      A nitric oxide donor reverses myocardial injury in rabbits with acute hypercholesterolemia.
      S Hoshida, N Yamashita, J Igarashi, M Nishida, M Hori, T Kuzuya and M Tada
      Journal of Pharmacology and Experimental Therapeutics August 1996, 278 (2) 741-746;
  17. Huang, Y T

    1. You have access
      Vascular hyporesponsiveness in aorta from portal hypertensive rats: possible sites of involvement.
      Y T Huang, G F Wang, M C Yang, S P Chang, H C Lin and C Y Hong
      Journal of Pharmacology and Experimental Therapeutics August 1996, 278 (2) 535-541;

I

  1. Ideguchi, Y

    1. You have access
      Platelet lipoxygenase inhibitors attenuate thrombin- and thromboxane mimetic-induced intracellular calcium mobilization and platelet aggregation.
      M D Nyby, M Sasaki, Y Ideguchi, H E Wynne, M T Hori, M E Berger, M S Golub, A S Brickman and M L Tuck
      Journal of Pharmacology and Experimental Therapeutics August 1996, 278 (2) 503-509;
  2. Igarashi, J

    1. You have access
      A nitric oxide donor reverses myocardial injury in rabbits with acute hypercholesterolemia.
      S Hoshida, N Yamashita, J Igarashi, M Nishida, M Hori, T Kuzuya and M Tada
      Journal of Pharmacology and Experimental Therapeutics August 1996, 278 (2) 741-746;
  3. Iino, T

    1. You have access
      Effect of vinconate, an indolonaphthyridine derivative, on dopamine and serotonin concentrations in dialysate from the striatum of freely moving rats: brain microdialysis studies.
      T Iino, M Katsura and K Kuriyama
      Journal of Pharmacology and Experimental Therapeutics August 1996, 278 (2) 614-619;
  4. Imaizumi, K

    1. You have access
      Effects of ONO-1101, a novel beta-antagonist, on action potential and membrane currents in cardiac muscle.
      K Muraki, H Nakagawa, N Nagano, S Henmi, H Kawasumi, T Nakanishi, K Imaizumi, T Tokuno, K Atsuki, Y Imaizumi and M Watanabe
      Journal of Pharmacology and Experimental Therapeutics August 1996, 278 (2) 555-563;
  5. Imaizumi, Y

    1. You have access
      Effects of ONO-1101, a novel beta-antagonist, on action potential and membrane currents in cardiac muscle.
      K Muraki, H Nakagawa, N Nagano, S Henmi, H Kawasumi, T Nakanishi, K Imaizumi, T Tokuno, K Atsuki, Y Imaizumi and M Watanabe
      Journal of Pharmacology and Experimental Therapeutics August 1996, 278 (2) 555-563;
  6. Imamura, H

    1. You have access
      Mechanism of stereoselective serum binding of ketoprofen after hemodialysis.
      T Sakai, T Maruyama, H Imamura, H Shimada and M Otagiri
      Journal of Pharmacology and Experimental Therapeutics August 1996, 278 (2) 786-792;
  7. Ishikawa, K

    1. You have access
      Carrier-mediated active transport of BQ-123, a peptidic endothelin antagonist, into rat hepatocytes.
      T Nakamura, A Hisaka, Y Sawasaki, Y Suzuki, T Fukami, K Ishikawa, M Yano and Y Sugiyama
      Journal of Pharmacology and Experimental Therapeutics August 1996, 278 (2) 564-572;
  8. Iyer, R P

    1. You have access
      Pharmacokinetics and tissue disposition of a chimeric oligodeoxynucleoside phosphorothioate in rats after intravenous administration.
      R Zhang, R P Iyer, D Yu, W Tan, X Zhang, Z Lu, H Zhao and S Agrawal
      Journal of Pharmacology and Experimental Therapeutics August 1996, 278 (2) 971-979;

J

  1. Jacobs, B L

    1. You have access
      WAY-100635, a potent and selective 5-hydroxytryptamine1A antagonist, increases serotonergic neuronal activity in behaving cats: comparison with (S)-WAY-100135.
      C A Fornal, C W Metzler, R A Gallegos, S C Veasey, A C McCreary and B L Jacobs
      Journal of Pharmacology and Experimental Therapeutics August 1996, 278 (2) 752-762;
  2. Jeannin, J F

    1. You have access
      Immunomodulator OM 163-induced reversal of tumor-mediated immunosuppression and downregulation of TGF-beta 1 in vivo.
      P Lagadec, S Reveneau, P Lejeune, D Pinard, T Borman, J Bauer and J F Jeannin
      Journal of Pharmacology and Experimental Therapeutics August 1996, 278 (2) 926-933;
  3. Johnson, E C

    1. You have access
      Cloning and functional characterization of human heteromeric N-methyl-D-aspartate receptors.
      S D Hess, L P Daggett, J Crona, C Deal, C C Lu, A Urrutia, L Chavez-Noriega, S B Ellis, E C Johnson and G Veliçelebi
      Journal of Pharmacology and Experimental Therapeutics August 1996, 278 (2) 808-816;

K

  1. Kan, H

    1. You have access
      Modulation by cyclic AMP of beta adrenergic receptor-stimulated prostacyclin synthesis in rabbit ventricular myocytes.
      Y Ruan, H Kan and K U Malik
      Journal of Pharmacology and Experimental Therapeutics August 1996, 278 (2) 482-489;
  2. Kato, Y

    1. You have access
      The endothelin receptor is a major determinant for the nonlinear tissue distribution of the endothelin antagonist BQ-123.
      H C Shin, Y Kato, Y Shitara, T Yamada, T Nakamura, A Hisaka and Y Sugiyama
      Journal of Pharmacology and Experimental Therapeutics August 1996, 278 (2) 607-613;
  3. Katsura, M

    1. You have access
      Effect of vinconate, an indolonaphthyridine derivative, on dopamine and serotonin concentrations in dialysate from the striatum of freely moving rats: brain microdialysis studies.
      T Iino, M Katsura and K Kuriyama
      Journal of Pharmacology and Experimental Therapeutics August 1996, 278 (2) 614-619;
  4. Kawai, H

    1. You have access
      Effects of a thrombin inhibitor, argatroban, on ischemic brain damage in the rat distal middle cerebral artery occlusion model.
      H Kawai, S Yuki, J Sugimoto and Y Tamao
      Journal of Pharmacology and Experimental Therapeutics August 1996, 278 (2) 780-785;
  5. Kawanishi, T

    1. You have access
      Use of chloride blockers: a novel approach for cardioprotection against ischemia-reperfusion damage.
      H Tanaka, S Matsui, T Kawanishi and K Shigenobu
      Journal of Pharmacology and Experimental Therapeutics August 1996, 278 (2) 854-861;
  6. Kawasumi, H

    1. You have access
      Effects of ONO-1101, a novel beta-antagonist, on action potential and membrane currents in cardiac muscle.
      K Muraki, H Nakagawa, N Nagano, S Henmi, H Kawasumi, T Nakanishi, K Imaizumi, T Tokuno, K Atsuki, Y Imaizumi and M Watanabe
      Journal of Pharmacology and Experimental Therapeutics August 1996, 278 (2) 555-563;
  7. Kessler, M

    1. You have access
      Effects of a memory-enhancing drug on DL-alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor currents and synaptic transmission in hippocampus.
      A Arai, M Kessler, G Rogers and G Lynch
      Journal of Pharmacology and Experimental Therapeutics August 1996, 278 (2) 627-638;
  8. Kiel, D

    1. You have access
      Phospholipase D activity regulates the binding of leukotriene B4 to human polymorphonuclear leukocytes.
      D Kiel and S J Feinmark
      Journal of Pharmacology and Experimental Therapeutics August 1996, 278 (2) 645-653;
  9. Klapper, L

    1. You have access
      Thrombin stimulates atrial natriuretic peptide secretion from rat cardiac atrium.
      L Klapper, S Nachshon, O Zamir and N Zamir
      Journal of Pharmacology and Experimental Therapeutics August 1996, 278 (2) 476-481;
  10. Klein, A

    1. You have access
      Neurokinetic and myokinetic effects of the peptide xenin on the motility of the small and large intestine of guinea pig.
      G E Feurle, A Klein, G Hamscher, J W Metzger and J A Schuurkes
      Journal of Pharmacology and Experimental Therapeutics August 1996, 278 (2) 654-661;
  11. Kuriyama, K

    1. You have access
      Effect of vinconate, an indolonaphthyridine derivative, on dopamine and serotonin concentrations in dialysate from the striatum of freely moving rats: brain microdialysis studies.
      T Iino, M Katsura and K Kuriyama
      Journal of Pharmacology and Experimental Therapeutics August 1996, 278 (2) 614-619;
  12. Kuzuya, T

    1. You have access
      A nitric oxide donor reverses myocardial injury in rabbits with acute hypercholesterolemia.
      S Hoshida, N Yamashita, J Igarashi, M Nishida, M Hori, T Kuzuya and M Tada
      Journal of Pharmacology and Experimental Therapeutics August 1996, 278 (2) 741-746;

L

  1. Laaris, N

    1. You have access
      Electrophysiological effects of N-(2-(4-(2-methoxyphenyl)-1-piperazinyl)ethyl)-N-(2-pyridinyl) cyclohexane carboxamide (WAY 100635) on dorsal raphe serotonergic neurons and CA1 hippocampal pyramidal cells in vitro.
      R Corradetti, E Le Poul, N Laaris, M Hamon and L Lanfumey
      Journal of Pharmacology and Experimental Therapeutics August 1996, 278 (2) 679-688;
  2. Laboulandine, I

    1. You have access
      Inhibition of both angiotensin-converting enzyme and neutral endopeptidase by S21402 (RB105) in rats with experimental myocardial infarction.
      W Gonzalez, F Beslot, I Laboulandine, M C Fournié-Zaluski, B P Roques and J B Michel
      Journal of Pharmacology and Experimental Therapeutics August 1996, 278 (2) 573-581;
  3. Lagadec, P

    1. You have access
      Immunomodulator OM 163-induced reversal of tumor-mediated immunosuppression and downregulation of TGF-beta 1 in vivo.
      P Lagadec, S Reveneau, P Lejeune, D Pinard, T Borman, J Bauer and J F Jeannin
      Journal of Pharmacology and Experimental Therapeutics August 1996, 278 (2) 926-933;
  4. Lamas, X

    1. You have access
      Acute and chronic effects of flupenthixol on the discriminative stimulus and reinforcing effects of cocaine in rhesus monkeys.
      S S Negus, N K Mello, X Lamas and J H Mendelson
      Journal of Pharmacology and Experimental Therapeutics August 1996, 278 (2) 879-890;
  5. Lanfumey, L

    1. You have access
      Electrophysiological effects of N-(2-(4-(2-methoxyphenyl)-1-piperazinyl)ethyl)-N-(2-pyridinyl) cyclohexane carboxamide (WAY 100635) on dorsal raphe serotonergic neurons and CA1 hippocampal pyramidal cells in vitro.
      R Corradetti, E Le Poul, N Laaris, M Hamon and L Lanfumey
      Journal of Pharmacology and Experimental Therapeutics August 1996, 278 (2) 679-688;
  6. Laudenslager, M L

    1. You have access
      Morphine-induced alterations in antibody levels: receptor and immune mechanisms.
      L L Lockwood, L H Silbert, M R Fleshner, C McNeal, L R Watkins, M L Laudenslager, K C Rice, R J Weber and S F Maier
      Journal of Pharmacology and Experimental Therapeutics August 1996, 278 (2) 689-696;
  7. Lee, H C

    1. You have access
      Mechanism of alpha-2 adrenergic modulation of canine cardiac Purkinje action potential.
      H C Lee, J J Cai, D O Arnar, E F Shibata and J B Martins
      Journal of Pharmacology and Experimental Therapeutics August 1996, 278 (2) 597-606;
  8. Le Fur, G

    1. You have access
      Characterization of two cloned human CB1 cannabinoid receptor isoforms.
      M Rinaldi-Carmona, B Calandra, D Shire, M Bouaboula, D Oustric, F Barth, P Casellas, P Ferrara and G Le Fur
      Journal of Pharmacology and Experimental Therapeutics August 1996, 278 (2) 871-878;
  9. Lejeune, P

    1. You have access
      Immunomodulator OM 163-induced reversal of tumor-mediated immunosuppression and downregulation of TGF-beta 1 in vivo.
      P Lagadec, S Reveneau, P Lejeune, D Pinard, T Borman, J Bauer and J F Jeannin
      Journal of Pharmacology and Experimental Therapeutics August 1996, 278 (2) 926-933;
  10. Le Poul, E

    1. You have access
      Electrophysiological effects of N-(2-(4-(2-methoxyphenyl)-1-piperazinyl)ethyl)-N-(2-pyridinyl) cyclohexane carboxamide (WAY 100635) on dorsal raphe serotonergic neurons and CA1 hippocampal pyramidal cells in vitro.
      R Corradetti, E Le Poul, N Laaris, M Hamon and L Lanfumey
      Journal of Pharmacology and Experimental Therapeutics August 1996, 278 (2) 679-688;
  11. Limberger, N

    1. You have access
      The presynaptic alpha-2 autoreceptors in pig brain cortex are alpha-2A.
      A U Trendelenburg, N Limberger and K Starke
      Journal of Pharmacology and Experimental Therapeutics August 1996, 278 (2) 462-467;
  12. Lin, H C

    1. You have access
      Vascular hyporesponsiveness in aorta from portal hypertensive rats: possible sites of involvement.
      Y T Huang, G F Wang, M C Yang, S P Chang, H C Lin and C Y Hong
      Journal of Pharmacology and Experimental Therapeutics August 1996, 278 (2) 535-541;
  13. Lin, K T

    1. You have access
      Leukotriene B4 modulates in vivo expression of delayed-type hypersensitivity by a receptor-mediated mechanism: regulation by lipoxin A4.
      Z Feng, H P Godfrey, S Mandy, S Strudwick, K T Lin, E Heilman and P Y Wong
      Journal of Pharmacology and Experimental Therapeutics August 1996, 278 (2) 950-956;
  14. Lockwood, L L

    1. You have access
      Morphine-induced alterations in antibody levels: receptor and immune mechanisms.
      L L Lockwood, L H Silbert, M R Fleshner, C McNeal, L R Watkins, M L Laudenslager, K C Rice, R J Weber and S F Maier
      Journal of Pharmacology and Experimental Therapeutics August 1996, 278 (2) 689-696;
  15. Lovinger, D M

    1. You have access
      Pharmacologic characteristics of potentiation of 5-HT3 receptors by alcohols and diethyl ether in NCB-20 neuroblastoma cells.
      Q Zhou and D M Lovinger
      Journal of Pharmacology and Experimental Therapeutics August 1996, 278 (2) 732-740;
  16. Lu, C C

    1. You have access
      Cloning and functional characterization of human heteromeric N-methyl-D-aspartate receptors.
      S D Hess, L P Daggett, J Crona, C Deal, C C Lu, A Urrutia, L Chavez-Noriega, S B Ellis, E C Johnson and G Veliçelebi
      Journal of Pharmacology and Experimental Therapeutics August 1996, 278 (2) 808-816;
  17. Lu, Z

    1. You have access
      Pharmacokinetics and tissue disposition of a chimeric oligodeoxynucleoside phosphorothioate in rats after intravenous administration.
      R Zhang, R P Iyer, D Yu, W Tan, X Zhang, Z Lu, H Zhao and S Agrawal
      Journal of Pharmacology and Experimental Therapeutics August 1996, 278 (2) 971-979;
  18. Luquita, M G

    1. You have access
      Ovine prolactin increases hepatic UDP-glucuronosyltransferase activity in ovariectomized rats.
      M G Luquita, V A Catania, E J Sánchez-Pozzi and A D Mottino
      Journal of Pharmacology and Experimental Therapeutics August 1996, 278 (2) 921-925;
  19. Lynch, G

    1. You have access
      Effects of a memory-enhancing drug on DL-alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor currents and synaptic transmission in hippocampus.
      A Arai, M Kessler, G Rogers and G Lynch
      Journal of Pharmacology and Experimental Therapeutics August 1996, 278 (2) 627-638;

M

  1. Maciejewski, D

    1. You have access
      Regulation of corticotropin-releasing factor-binding protein expression in cultured rat astrocytes.
      D Maciejewski, P D Crowe, E B De Souza and D P Behan
      Journal of Pharmacology and Experimental Therapeutics August 1996, 278 (2) 455-461;
  2. Macrez-Leprêtre, N

    1. You have access
      Angiotensin II-mediated activation of L-type calcium channels involves phosphatidylinositol hydrolysis-independent activation of protein kinase C in rat portal vein myocytes.
      N Macrez-Leprêtre, J L Morel and J Mironneau
      Journal of Pharmacology and Experimental Therapeutics August 1996, 278 (2) 468-475;
  3. Maier, S F

    1. You have access
      Morphine-induced alterations in antibody levels: receptor and immune mechanisms.
      L L Lockwood, L H Silbert, M R Fleshner, C McNeal, L R Watkins, M L Laudenslager, K C Rice, R J Weber and S F Maier
      Journal of Pharmacology and Experimental Therapeutics August 1996, 278 (2) 689-696;
  4. Malik, K U

    1. You have access
      Modulation by cyclic AMP of beta adrenergic receptor-stimulated prostacyclin synthesis in rabbit ventricular myocytes.
      Y Ruan, H Kan and K U Malik
      Journal of Pharmacology and Experimental Therapeutics August 1996, 278 (2) 482-489;
  5. Mandy, S

    1. You have access
      Leukotriene B4 modulates in vivo expression of delayed-type hypersensitivity by a receptor-mediated mechanism: regulation by lipoxin A4.
      Z Feng, H P Godfrey, S Mandy, S Strudwick, K T Lin, E Heilman and P Y Wong
      Journal of Pharmacology and Experimental Therapeutics August 1996, 278 (2) 950-956;
  6. Martins, J B

    1. You have access
      Mechanism of alpha-2 adrenergic modulation of canine cardiac Purkinje action potential.
      H C Lee, J J Cai, D O Arnar, E F Shibata and J B Martins
      Journal of Pharmacology and Experimental Therapeutics August 1996, 278 (2) 597-606;
  7. Maruyama, T

    1. You have access
      Mechanism of stereoselective serum binding of ketoprofen after hemodialysis.
      T Sakai, T Maruyama, H Imamura, H Shimada and M Otagiri
      Journal of Pharmacology and Experimental Therapeutics August 1996, 278 (2) 786-792;
  8. Matsuda, T

    1. You have access
      Novel benzodioxan derivative, 5-[3-[((2S)-1,4-benzodioxan-2-ylmethyl) amino]propoxy]-1,3-benzodioxole HCl (MKC-242), with anxiolytic-like and antidepressant-like effects in animal models.
      M Abe, R Tabata, K Saito, T Matsuda, A Baba and M Egawa
      Journal of Pharmacology and Experimental Therapeutics August 1996, 278 (2) 898-905;
  9. Matsui, S

    1. You have access
      Use of chloride blockers: a novel approach for cardioprotection against ischemia-reperfusion damage.
      H Tanaka, S Matsui, T Kawanishi and K Shigenobu
      Journal of Pharmacology and Experimental Therapeutics August 1996, 278 (2) 854-861;
  10. Matsuoka, N

    1. You have access
      D-cycloserine, a partial agonist at the glycine site coupled to N-methyl-D-aspartate receptors, improves visual recognition memory in rhesus monkeys.
      N Matsuoka and T G Aigner
      Journal of Pharmacology and Experimental Therapeutics August 1996, 278 (2) 891-897;
  11. Mayersohn, M

    1. You have access
      Antiphencyclidine monoclonal Fab fragments reverse phencyclidine-induced behavioral effects and ataxia in rats.
      J L Valentine, M Mayersohn, W D Wessinger, L W Arnold and S M Owens
      Journal of Pharmacology and Experimental Therapeutics August 1996, 278 (2) 709-716;
  12. McCreary, A C

    1. You have access
      WAY-100635, a potent and selective 5-hydroxytryptamine1A antagonist, increases serotonergic neuronal activity in behaving cats: comparison with (S)-WAY-100135.
      C A Fornal, C W Metzler, R A Gallegos, S C Veasey, A C McCreary and B L Jacobs
      Journal of Pharmacology and Experimental Therapeutics August 1996, 278 (2) 752-762;
  13. McGiff, J C

    1. You have access
      Role of phospholipase C and phospholipase A2 in the nitric oxide-independent vasodilator effect of bradykinin in the rat perfused heart.
      D Fulton, J C McGiff and J Quilley
      Journal of Pharmacology and Experimental Therapeutics August 1996, 278 (2) 518-526;
  14. McNeal, C

    1. You have access
      Morphine-induced alterations in antibody levels: receptor and immune mechanisms.
      L L Lockwood, L H Silbert, M R Fleshner, C McNeal, L R Watkins, M L Laudenslager, K C Rice, R J Weber and S F Maier
      Journal of Pharmacology and Experimental Therapeutics August 1996, 278 (2) 689-696;
  15. Meeker, S

    1. You have access
      Inhibition by zinc protoporphyrin-IX of vasoactive intestinal peptide-induced relaxations of guinea pig isolated trachea.
      B J Undem, J L Ellis, S Meeker, A Fischer and B J Canning
      Journal of Pharmacology and Experimental Therapeutics August 1996, 278 (2) 964-970;
  16. Mello, N K

    1. You have access
      Acute and chronic effects of flupenthixol on the discriminative stimulus and reinforcing effects of cocaine in rhesus monkeys.
      S S Negus, N K Mello, X Lamas and J H Mendelson
      Journal of Pharmacology and Experimental Therapeutics August 1996, 278 (2) 879-890;
  17. Mendelson, J H

    1. You have access
      Acute and chronic effects of flupenthixol on the discriminative stimulus and reinforcing effects of cocaine in rhesus monkeys.
      S S Negus, N K Mello, X Lamas and J H Mendelson
      Journal of Pharmacology and Experimental Therapeutics August 1996, 278 (2) 879-890;
  18. Metzger, J W

    1. You have access
      Neurokinetic and myokinetic effects of the peptide xenin on the motility of the small and large intestine of guinea pig.
      G E Feurle, A Klein, G Hamscher, J W Metzger and J A Schuurkes
      Journal of Pharmacology and Experimental Therapeutics August 1996, 278 (2) 654-661;
  19. Metzger, W J

    1. You have access
      Simultaneous measurement of cyclopentyladenosine-induced contraction and intracellular calcium in bronchial rings from allergic rabbits and it's antagonism.
      S Ali, W J Metzger and S J Mustafa
      Journal of Pharmacology and Experimental Therapeutics August 1996, 278 (2) 639-644;
  20. Metzler, C W

    1. You have access
      WAY-100635, a potent and selective 5-hydroxytryptamine1A antagonist, increases serotonergic neuronal activity in behaving cats: comparison with (S)-WAY-100135.
      C A Fornal, C W Metzler, R A Gallegos, S C Veasey, A C McCreary and B L Jacobs
      Journal of Pharmacology and Experimental Therapeutics August 1996, 278 (2) 752-762;
  21. Michel, J B

    1. You have access
      Inhibition of both angiotensin-converting enzyme and neutral endopeptidase by S21402 (RB105) in rats with experimental myocardial infarction.
      W Gonzalez, F Beslot, I Laboulandine, M C Fournié-Zaluski, B P Roques and J B Michel
      Journal of Pharmacology and Experimental Therapeutics August 1996, 278 (2) 573-581;
  22. Mironneau, J

    1. You have access
      Angiotensin II-mediated activation of L-type calcium channels involves phosphatidylinositol hydrolysis-independent activation of protein kinase C in rat portal vein myocytes.
      N Macrez-Leprêtre, J L Morel and J Mironneau
      Journal of Pharmacology and Experimental Therapeutics August 1996, 278 (2) 468-475;
  23. Morais, R

    1. You have access
      Chloramphenicol and the inflammatory response in the rat. Upregulation of the gene for T2-kininogen in liver.
      P Raymond, H Wang, C Blais, A Décarie, A Adam and R Morais
      Journal of Pharmacology and Experimental Therapeutics August 1996, 278 (2) 934-940;
  24. Morel, J L

    1. You have access
      Angiotensin II-mediated activation of L-type calcium channels involves phosphatidylinositol hydrolysis-independent activation of protein kinase C in rat portal vein myocytes.
      N Macrez-Leprêtre, J L Morel and J Mironneau
      Journal of Pharmacology and Experimental Therapeutics August 1996, 278 (2) 468-475;
  25. Morrow, A L

    1. You have access
      Sensitization of gamma-aminobutyric acidA receptors to neuroactive steroids in rats during ethanol withdrawal.
      L L Devaud, R H Purdy, D A Finn and A L Morrow
      Journal of Pharmacology and Experimental Therapeutics August 1996, 278 (2) 510-517;
  26. Mottino, A D

    1. You have access
      Ovine prolactin increases hepatic UDP-glucuronosyltransferase activity in ovariectomized rats.
      M G Luquita, V A Catania, E J Sánchez-Pozzi and A D Mottino
      Journal of Pharmacology and Experimental Therapeutics August 1996, 278 (2) 921-925;
  27. Muraki, K

    1. You have access
      Effects of ONO-1101, a novel beta-antagonist, on action potential and membrane currents in cardiac muscle.
      K Muraki, H Nakagawa, N Nagano, S Henmi, H Kawasumi, T Nakanishi, K Imaizumi, T Tokuno, K Atsuki, Y Imaizumi and M Watanabe
      Journal of Pharmacology and Experimental Therapeutics August 1996, 278 (2) 555-563;
  28. Mustafa, S J

    1. You have access
      Simultaneous measurement of cyclopentyladenosine-induced contraction and intracellular calcium in bronchial rings from allergic rabbits and it's antagonism.
      S Ali, W J Metzger and S J Mustafa
      Journal of Pharmacology and Experimental Therapeutics August 1996, 278 (2) 639-644;

N

  1. Nachshon, S

    1. You have access
      Thrombin stimulates atrial natriuretic peptide secretion from rat cardiac atrium.
      L Klapper, S Nachshon, O Zamir and N Zamir
      Journal of Pharmacology and Experimental Therapeutics August 1996, 278 (2) 476-481;
  2. Nadeson, R

    1. You have access
      gamma-Aminobutyric acidA receptors and spinally mediated antinociception in rats.
      R Nadeson, Z Guo, V Porter, J P Gent and C S Goodchild
      Journal of Pharmacology and Experimental Therapeutics August 1996, 278 (2) 620-626;
  3. Nagano, N

    1. You have access
      Effects of ONO-1101, a novel beta-antagonist, on action potential and membrane currents in cardiac muscle.
      K Muraki, H Nakagawa, N Nagano, S Henmi, H Kawasumi, T Nakanishi, K Imaizumi, T Tokuno, K Atsuki, Y Imaizumi and M Watanabe
      Journal of Pharmacology and Experimental Therapeutics August 1996, 278 (2) 555-563;
  4. Nakagawa, H

    1. You have access
      Effects of ONO-1101, a novel beta-antagonist, on action potential and membrane currents in cardiac muscle.
      K Muraki, H Nakagawa, N Nagano, S Henmi, H Kawasumi, T Nakanishi, K Imaizumi, T Tokuno, K Atsuki, Y Imaizumi and M Watanabe
      Journal of Pharmacology and Experimental Therapeutics August 1996, 278 (2) 555-563;
  5. Nakamura, T

    1. You have access
      Carrier-mediated active transport of BQ-123, a peptidic endothelin antagonist, into rat hepatocytes.
      T Nakamura, A Hisaka, Y Sawasaki, Y Suzuki, T Fukami, K Ishikawa, M Yano and Y Sugiyama
      Journal of Pharmacology and Experimental Therapeutics August 1996, 278 (2) 564-572;
    2. You have access
      The endothelin receptor is a major determinant for the nonlinear tissue distribution of the endothelin antagonist BQ-123.
      H C Shin, Y Kato, Y Shitara, T Yamada, T Nakamura, A Hisaka and Y Sugiyama
      Journal of Pharmacology and Experimental Therapeutics August 1996, 278 (2) 607-613;
  6. Nakanishi, T

    1. You have access
      Effects of ONO-1101, a novel beta-antagonist, on action potential and membrane currents in cardiac muscle.
      K Muraki, H Nakagawa, N Nagano, S Henmi, H Kawasumi, T Nakanishi, K Imaizumi, T Tokuno, K Atsuki, Y Imaizumi and M Watanabe
      Journal of Pharmacology and Experimental Therapeutics August 1996, 278 (2) 555-563;
  7. Negus, S S

    1. You have access
      Acute and chronic effects of flupenthixol on the discriminative stimulus and reinforcing effects of cocaine in rhesus monkeys.
      S S Negus, N K Mello, X Lamas and J H Mendelson
      Journal of Pharmacology and Experimental Therapeutics August 1996, 278 (2) 879-890;
  8. Nishida, M

    1. You have access
      A nitric oxide donor reverses myocardial injury in rabbits with acute hypercholesterolemia.
      S Hoshida, N Yamashita, J Igarashi, M Nishida, M Hori, T Kuzuya and M Tada
      Journal of Pharmacology and Experimental Therapeutics August 1996, 278 (2) 741-746;
  9. Nyby, M D

    1. You have access
      Platelet lipoxygenase inhibitors attenuate thrombin- and thromboxane mimetic-induced intracellular calcium mobilization and platelet aggregation.
      M D Nyby, M Sasaki, Y Ideguchi, H E Wynne, M T Hori, M E Berger, M S Golub, A S Brickman and M L Tuck
      Journal of Pharmacology and Experimental Therapeutics August 1996, 278 (2) 503-509;

O

  1. Olson, L

    1. You have access
      A comparison of the effects of glial cell line-derived neurotrophic factor on spinal cord and cortex cerebri grafts.
      K Trok, S Almström and L Olson
      Journal of Pharmacology and Experimental Therapeutics August 1996, 278 (2) 941-949;
  2. Ooie, T

    1. You have access
      Comparative distribution of quinolone antibiotics in cerebrospinal fluid and brain in rats and dogs.
      T Ooie, H Suzuki, T Terasaki and Y Sugiyama
      Journal of Pharmacology and Experimental Therapeutics August 1996, 278 (2) 590-596;
  3. Otagiri, M

    1. You have access
      Mechanism of stereoselective serum binding of ketoprofen after hemodialysis.
      T Sakai, T Maruyama, H Imamura, H Shimada and M Otagiri
      Journal of Pharmacology and Experimental Therapeutics August 1996, 278 (2) 786-792;
  4. Oustric, D

    1. You have access
      Characterization of two cloned human CB1 cannabinoid receptor isoforms.
      M Rinaldi-Carmona, B Calandra, D Shire, M Bouaboula, D Oustric, F Barth, P Casellas, P Ferrara and G Le Fur
      Journal of Pharmacology and Experimental Therapeutics August 1996, 278 (2) 871-878;
  5. Owens, S M

    1. You have access
      Antiphencyclidine monoclonal Fab fragments reverse phencyclidine-induced behavioral effects and ataxia in rats.
      J L Valentine, M Mayersohn, W D Wessinger, L W Arnold and S M Owens
      Journal of Pharmacology and Experimental Therapeutics August 1996, 278 (2) 709-716;
    2. You have access
      Antiphencyclidine monoclonal antibody therapy significantly changes phencyclidine concentrations in brain and other tissues in rats.
      J L Valentine and S M Owens
      Journal of Pharmacology and Experimental Therapeutics August 1996, 278 (2) 717-724;

P

  1. Paciorek, P M

    1. You have access
      Pharmacological evidence for tumor necrosis factor as a mediator of allergic inflammation in the airways.
      L M Renzetti, P M Paciorek, S A Tannu, N C Rinaldi, J E Tocker, M A Wasserman and P R Gater
      Journal of Pharmacology and Experimental Therapeutics August 1996, 278 (2) 847-853;
  2. Pan, W H

    1. You have access
      Locally application of amphetamine into the ventral tegmental area enhances dopamine release in the nucleus accumbens and the medial prefrontal cortex through noradrenergic neurotransmission.
      W H Pan, J C Sung and S M Fuh
      Journal of Pharmacology and Experimental Therapeutics August 1996, 278 (2) 725-731;
  3. Pandolfo, L

    1. You have access
      Mechanisms of plumbagin action on guinea pig isolated atria.
      M Floreani, A Forlin, L Pandolfo, M Petrone and S Bellin
      Journal of Pharmacology and Experimental Therapeutics August 1996, 278 (2) 763-770;
  4. Paudice, P

    1. You have access
      Human brain cholecystokinin: release of cholecystokinin-like immunoreactivity (CCK-LI) from isolated cortical nerve endings and its modulation through GABA(B) receptors.
      M Raiteri, G Bonanno, P Paudice, P Cavazzani and G Schmid
      Journal of Pharmacology and Experimental Therapeutics August 1996, 278 (2) 747-751;
  5. Petrone, M

    1. You have access
      Mechanisms of plumbagin action on guinea pig isolated atria.
      M Floreani, A Forlin, L Pandolfo, M Petrone and S Bellin
      Journal of Pharmacology and Experimental Therapeutics August 1996, 278 (2) 763-770;
  6. Pinard, D

    1. You have access
      Immunomodulator OM 163-induced reversal of tumor-mediated immunosuppression and downregulation of TGF-beta 1 in vivo.
      P Lagadec, S Reveneau, P Lejeune, D Pinard, T Borman, J Bauer and J F Jeannin
      Journal of Pharmacology and Experimental Therapeutics August 1996, 278 (2) 926-933;
  7. Porter, V

    1. You have access
      gamma-Aminobutyric acidA receptors and spinally mediated antinociception in rats.
      R Nadeson, Z Guo, V Porter, J P Gent and C S Goodchild
      Journal of Pharmacology and Experimental Therapeutics August 1996, 278 (2) 620-626;
  8. Preston, K L

    1. You have access
      Buprenorphine, morphine and naloxone effects during ascending morphine maintenance in humans.
      K J Schuh, S L Walsh, G E Bigelow, K L Preston and M L Stitzer
      Journal of Pharmacology and Experimental Therapeutics August 1996, 278 (2) 836-846;
  9. Pritchard, J B

    1. You have access
      Mechanism mediating basolateral transport of 2,4-dichlorophenoxyacetic acid in rat kidney.
      A R Villalobos, C A Dunnick and J B Pritchard
      Journal of Pharmacology and Experimental Therapeutics August 1996, 278 (2) 582-589;
  10. Purdy, R H

    1. You have access
      Sensitization of gamma-aminobutyric acidA receptors to neuroactive steroids in rats during ethanol withdrawal.
      L L Devaud, R H Purdy, D A Finn and A L Morrow
      Journal of Pharmacology and Experimental Therapeutics August 1996, 278 (2) 510-517;

Q

  1. Quilley, J

    1. You have access
      Role of phospholipase C and phospholipase A2 in the nitric oxide-independent vasodilator effect of bradykinin in the rat perfused heart.
      D Fulton, J C McGiff and J Quilley
      Journal of Pharmacology and Experimental Therapeutics August 1996, 278 (2) 518-526;

R

  1. Raiteri, M

    1. You have access
      Human brain cholecystokinin: release of cholecystokinin-like immunoreactivity (CCK-LI) from isolated cortical nerve endings and its modulation through GABA(B) receptors.
      M Raiteri, G Bonanno, P Paudice, P Cavazzani and G Schmid
      Journal of Pharmacology and Experimental Therapeutics August 1996, 278 (2) 747-751;
  2. Raymond, P

    1. You have access
      Chloramphenicol and the inflammatory response in the rat. Upregulation of the gene for T2-kininogen in liver.
      P Raymond, H Wang, C Blais, A Décarie, A Adam and R Morais
      Journal of Pharmacology and Experimental Therapeutics August 1996, 278 (2) 934-940;
  3. Reid, I A

    1. You have access
      Role of cyclic GMP-inhibitable phosphodiesterase and nitric oxide in the beta adrenoceptor control of renin secretion.
      T Chiu and I A Reid
      Journal of Pharmacology and Experimental Therapeutics August 1996, 278 (2) 793-799;
  4. Renzetti, L M

    1. You have access
      Pharmacological evidence for tumor necrosis factor as a mediator of allergic inflammation in the airways.
      L M Renzetti, P M Paciorek, S A Tannu, N C Rinaldi, J E Tocker, M A Wasserman and P R Gater
      Journal of Pharmacology and Experimental Therapeutics August 1996, 278 (2) 847-853;
  5. Reveneau, S

    1. You have access
      Immunomodulator OM 163-induced reversal of tumor-mediated immunosuppression and downregulation of TGF-beta 1 in vivo.
      P Lagadec, S Reveneau, P Lejeune, D Pinard, T Borman, J Bauer and J F Jeannin
      Journal of Pharmacology and Experimental Therapeutics August 1996, 278 (2) 926-933;
  6. Rice, K C

    1. You have access
      Morphine-induced alterations in antibody levels: receptor and immune mechanisms.
      L L Lockwood, L H Silbert, M R Fleshner, C McNeal, L R Watkins, M L Laudenslager, K C Rice, R J Weber and S F Maier
      Journal of Pharmacology and Experimental Therapeutics August 1996, 278 (2) 689-696;
  7. Rinaldi, N C

    1. You have access
      Pharmacological evidence for tumor necrosis factor as a mediator of allergic inflammation in the airways.
      L M Renzetti, P M Paciorek, S A Tannu, N C Rinaldi, J E Tocker, M A Wasserman and P R Gater
      Journal of Pharmacology and Experimental Therapeutics August 1996, 278 (2) 847-853;
  8. Rinaldi-Carmona, M

    1. You have access
      Characterization of two cloned human CB1 cannabinoid receptor isoforms.
      M Rinaldi-Carmona, B Calandra, D Shire, M Bouaboula, D Oustric, F Barth, P Casellas, P Ferrara and G Le Fur
      Journal of Pharmacology and Experimental Therapeutics August 1996, 278 (2) 871-878;
  9. Roehr, J E

    1. You have access
      Ex vivo studies with iloperidone (HP 873), a potential atypical antipsychotic with dopamine D2/5-hydroxytryptamine2 receptor antagonist activity.
      A M Szczepanik, L R Brougham, J E Roehr, P G Conway, D B Ellis and C A Wilmot
      Journal of Pharmacology and Experimental Therapeutics August 1996, 278 (2) 913-920;
  10. Rogers, G

    1. You have access
      Effects of a memory-enhancing drug on DL-alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor currents and synaptic transmission in hippocampus.
      A Arai, M Kessler, G Rogers and G Lynch
      Journal of Pharmacology and Experimental Therapeutics August 1996, 278 (2) 627-638;
  11. Romero, J A

    1. You have access
      Effect of quercitrin on acute and chronic experimental colitis in the rat.
      F Sánchez de Medina, J Gálvez, J A Romero and A Zarzuelo
      Journal of Pharmacology and Experimental Therapeutics August 1996, 278 (2) 771-779;
  12. Roques, B P

    1. You have access
      Inhibition of both angiotensin-converting enzyme and neutral endopeptidase by S21402 (RB105) in rats with experimental myocardial infarction.
      W Gonzalez, F Beslot, I Laboulandine, M C Fournié-Zaluski, B P Roques and J B Michel
      Journal of Pharmacology and Experimental Therapeutics August 1996, 278 (2) 573-581;
  13. Rosen, M R

    1. You have access
      Chronic in vivo and in vitro effects of amiodarone on guinea pig hearts.
      E A Sosunov, E P Anyukhovsky and M R Rosen
      Journal of Pharmacology and Experimental Therapeutics August 1996, 278 (2) 906-912;
  14. Ruan, Y

    1. You have access
      Modulation by cyclic AMP of beta adrenergic receptor-stimulated prostacyclin synthesis in rabbit ventricular myocytes.
      Y Ruan, H Kan and K U Malik
      Journal of Pharmacology and Experimental Therapeutics August 1996, 278 (2) 482-489;

S

  1. Saito, K

    1. You have access
      Novel benzodioxan derivative, 5-[3-[((2S)-1,4-benzodioxan-2-ylmethyl) amino]propoxy]-1,3-benzodioxole HCl (MKC-242), with anxiolytic-like and antidepressant-like effects in animal models.
      M Abe, R Tabata, K Saito, T Matsuda, A Baba and M Egawa
      Journal of Pharmacology and Experimental Therapeutics August 1996, 278 (2) 898-905;
  2. Sakai, T

    1. You have access
      Mechanism of stereoselective serum binding of ketoprofen after hemodialysis.
      T Sakai, T Maruyama, H Imamura, H Shimada and M Otagiri
      Journal of Pharmacology and Experimental Therapeutics August 1996, 278 (2) 786-792;
  3. Sánchez-Pozzi, E J

    1. You have access
      Ovine prolactin increases hepatic UDP-glucuronosyltransferase activity in ovariectomized rats.
      M G Luquita, V A Catania, E J Sánchez-Pozzi and A D Mottino
      Journal of Pharmacology and Experimental Therapeutics August 1996, 278 (2) 921-925;
  4. Sánchez de Medina, F

    1. You have access
      Effect of quercitrin on acute and chronic experimental colitis in the rat.
      F Sánchez de Medina, J Gálvez, J A Romero and A Zarzuelo
      Journal of Pharmacology and Experimental Therapeutics August 1996, 278 (2) 771-779;
  5. Sasaki, M

    1. You have access
      Platelet lipoxygenase inhibitors attenuate thrombin- and thromboxane mimetic-induced intracellular calcium mobilization and platelet aggregation.
      M D Nyby, M Sasaki, Y Ideguchi, H E Wynne, M T Hori, M E Berger, M S Golub, A S Brickman and M L Tuck
      Journal of Pharmacology and Experimental Therapeutics August 1996, 278 (2) 503-509;
  6. Satoh, H

    1. You have access
      Ca(++)-dependence of caffeine modulation of the rate-force relation in canine cardiac Purkinje fibers.
      H Satoh and M Vassalle
      Journal of Pharmacology and Experimental Therapeutics August 1996, 278 (2) 826-835;
  7. Sawasaki, Y

    1. You have access
      Carrier-mediated active transport of BQ-123, a peptidic endothelin antagonist, into rat hepatocytes.
      T Nakamura, A Hisaka, Y Sawasaki, Y Suzuki, T Fukami, K Ishikawa, M Yano and Y Sugiyama
      Journal of Pharmacology and Experimental Therapeutics August 1996, 278 (2) 564-572;
  8. Schmid, G

    1. You have access
      Human brain cholecystokinin: release of cholecystokinin-like immunoreactivity (CCK-LI) from isolated cortical nerve endings and its modulation through GABA(B) receptors.
      M Raiteri, G Bonanno, P Paudice, P Cavazzani and G Schmid
      Journal of Pharmacology and Experimental Therapeutics August 1996, 278 (2) 747-751;
  9. Schmidt, B H

    1. You have access
      Effects of metrifonate, its transformation product dichlorvos, and other organophosphorus and reference cholinesterase inhibitors on Morris water escape behavior in young-adult rats.
      F J van der Staay, V C Hinz and B H Schmidt
      Journal of Pharmacology and Experimental Therapeutics August 1996, 278 (2) 697-708;
  10. Schuh, K J

    1. You have access
      Buprenorphine, morphine and naloxone effects during ascending morphine maintenance in humans.
      K J Schuh, S L Walsh, G E Bigelow, K L Preston and M L Stitzer
      Journal of Pharmacology and Experimental Therapeutics August 1996, 278 (2) 836-846;
  11. Schuurkes, J A

    1. You have access
      Neurokinetic and myokinetic effects of the peptide xenin on the motility of the small and large intestine of guinea pig.
      G E Feurle, A Klein, G Hamscher, J W Metzger and J A Schuurkes
      Journal of Pharmacology and Experimental Therapeutics August 1996, 278 (2) 654-661;
  12. Scott, M

    1. You have access
      Morphine suppresses the alloantigen-driven CTL response in a dose-dependent and naltrexone reversible manner.
      M Scott and D J Carr
      Journal of Pharmacology and Experimental Therapeutics August 1996, 278 (2) 980-988;
  13. Shibata, E F

    1. You have access
      Mechanism of alpha-2 adrenergic modulation of canine cardiac Purkinje action potential.
      H C Lee, J J Cai, D O Arnar, E F Shibata and J B Martins
      Journal of Pharmacology and Experimental Therapeutics August 1996, 278 (2) 597-606;
  14. Shigenobu, K

    1. You have access
      Use of chloride blockers: a novel approach for cardioprotection against ischemia-reperfusion damage.
      H Tanaka, S Matsui, T Kawanishi and K Shigenobu
      Journal of Pharmacology and Experimental Therapeutics August 1996, 278 (2) 854-861;
  15. Shimada, H

    1. You have access
      Mechanism of stereoselective serum binding of ketoprofen after hemodialysis.
      T Sakai, T Maruyama, H Imamura, H Shimada and M Otagiri
      Journal of Pharmacology and Experimental Therapeutics August 1996, 278 (2) 786-792;
  16. Shin, H C

    1. You have access
      The endothelin receptor is a major determinant for the nonlinear tissue distribution of the endothelin antagonist BQ-123.
      H C Shin, Y Kato, Y Shitara, T Yamada, T Nakamura, A Hisaka and Y Sugiyama
      Journal of Pharmacology and Experimental Therapeutics August 1996, 278 (2) 607-613;
  17. Shippenberg, T S

    1. You have access
      Role of extracellular dopamine in the initiation and long-term expression of behavioral sensitization to cocaine.
      C A Heidbreder, A C Thompson and T S Shippenberg
      Journal of Pharmacology and Experimental Therapeutics August 1996, 278 (2) 490-502;
  18. Shire, D

    1. You have access
      Characterization of two cloned human CB1 cannabinoid receptor isoforms.
      M Rinaldi-Carmona, B Calandra, D Shire, M Bouaboula, D Oustric, F Barth, P Casellas, P Ferrara and G Le Fur
      Journal of Pharmacology and Experimental Therapeutics August 1996, 278 (2) 871-878;
  19. Shitara, Y

    1. You have access
      The endothelin receptor is a major determinant for the nonlinear tissue distribution of the endothelin antagonist BQ-123.
      H C Shin, Y Kato, Y Shitara, T Yamada, T Nakamura, A Hisaka and Y Sugiyama
      Journal of Pharmacology and Experimental Therapeutics August 1996, 278 (2) 607-613;
  20. Silbert, L H

    1. You have access
      Morphine-induced alterations in antibody levels: receptor and immune mechanisms.
      L L Lockwood, L H Silbert, M R Fleshner, C McNeal, L R Watkins, M L Laudenslager, K C Rice, R J Weber and S F Maier
      Journal of Pharmacology and Experimental Therapeutics August 1996, 278 (2) 689-696;
  21. Skerjanec, A

    1. You have access
      Mechanisms of nonlinear pharmacokinetics of mibefradil in chronically instrumented dogs.
      A Skerjanec, S Tawfik and Y K Tam
      Journal of Pharmacology and Experimental Therapeutics August 1996, 278 (2) 817-825;
  22. Sosunov, E A

    1. You have access
      Chronic in vivo and in vitro effects of amiodarone on guinea pig hearts.
      E A Sosunov, E P Anyukhovsky and M R Rosen
      Journal of Pharmacology and Experimental Therapeutics August 1996, 278 (2) 906-912;
  23. Starke, K

    1. You have access
      The presynaptic alpha-2 autoreceptors in pig brain cortex are alpha-2A.
      A U Trendelenburg, N Limberger and K Starke
      Journal of Pharmacology and Experimental Therapeutics August 1996, 278 (2) 462-467;
  24. Stitzer, M L

    1. You have access
      Buprenorphine, morphine and naloxone effects during ascending morphine maintenance in humans.
      K J Schuh, S L Walsh, G E Bigelow, K L Preston and M L Stitzer
      Journal of Pharmacology and Experimental Therapeutics August 1996, 278 (2) 836-846;
  25. Strudwick, S

    1. You have access
      Leukotriene B4 modulates in vivo expression of delayed-type hypersensitivity by a receptor-mediated mechanism: regulation by lipoxin A4.
      Z Feng, H P Godfrey, S Mandy, S Strudwick, K T Lin, E Heilman and P Y Wong
      Journal of Pharmacology and Experimental Therapeutics August 1996, 278 (2) 950-956;
  26. Sugimoto, J

    1. You have access
      Effects of a thrombin inhibitor, argatroban, on ischemic brain damage in the rat distal middle cerebral artery occlusion model.
      H Kawai, S Yuki, J Sugimoto and Y Tamao
      Journal of Pharmacology and Experimental Therapeutics August 1996, 278 (2) 780-785;
  27. Sugiyama, Y

    1. You have access
      Carrier-mediated active transport of BQ-123, a peptidic endothelin antagonist, into rat hepatocytes.
      T Nakamura, A Hisaka, Y Sawasaki, Y Suzuki, T Fukami, K Ishikawa, M Yano and Y Sugiyama
      Journal of Pharmacology and Experimental Therapeutics August 1996, 278 (2) 564-572;
    2. You have access
      Comparative distribution of quinolone antibiotics in cerebrospinal fluid and brain in rats and dogs.
      T Ooie, H Suzuki, T Terasaki and Y Sugiyama
      Journal of Pharmacology and Experimental Therapeutics August 1996, 278 (2) 590-596;
    3. You have access
      The endothelin receptor is a major determinant for the nonlinear tissue distribution of the endothelin antagonist BQ-123.
      H C Shin, Y Kato, Y Shitara, T Yamada, T Nakamura, A Hisaka and Y Sugiyama
      Journal of Pharmacology and Experimental Therapeutics August 1996, 278 (2) 607-613;
  28. Sung, J C

    1. You have access
      Locally application of amphetamine into the ventral tegmental area enhances dopamine release in the nucleus accumbens and the medial prefrontal cortex through noradrenergic neurotransmission.
      W H Pan, J C Sung and S M Fuh
      Journal of Pharmacology and Experimental Therapeutics August 1996, 278 (2) 725-731;
  29. Suzuki, H

    1. You have access
      Comparative distribution of quinolone antibiotics in cerebrospinal fluid and brain in rats and dogs.
      T Ooie, H Suzuki, T Terasaki and Y Sugiyama
      Journal of Pharmacology and Experimental Therapeutics August 1996, 278 (2) 590-596;
  30. Suzuki, Y

    1. You have access
      Carrier-mediated active transport of BQ-123, a peptidic endothelin antagonist, into rat hepatocytes.
      T Nakamura, A Hisaka, Y Sawasaki, Y Suzuki, T Fukami, K Ishikawa, M Yano and Y Sugiyama
      Journal of Pharmacology and Experimental Therapeutics August 1996, 278 (2) 564-572;
  31. Szczepanik, A M

    1. You have access
      Ex vivo studies with iloperidone (HP 873), a potential atypical antipsychotic with dopamine D2/5-hydroxytryptamine2 receptor antagonist activity.
      A M Szczepanik, L R Brougham, J E Roehr, P G Conway, D B Ellis and C A Wilmot
      Journal of Pharmacology and Experimental Therapeutics August 1996, 278 (2) 913-920;

T

  1. Tabata, R

    1. You have access
      Novel benzodioxan derivative, 5-[3-[((2S)-1,4-benzodioxan-2-ylmethyl) amino]propoxy]-1,3-benzodioxole HCl (MKC-242), with anxiolytic-like and antidepressant-like effects in animal models.
      M Abe, R Tabata, K Saito, T Matsuda, A Baba and M Egawa
      Journal of Pharmacology and Experimental Therapeutics August 1996, 278 (2) 898-905;
  2. Tada, M

    1. You have access
      A nitric oxide donor reverses myocardial injury in rabbits with acute hypercholesterolemia.
      S Hoshida, N Yamashita, J Igarashi, M Nishida, M Hori, T Kuzuya and M Tada
      Journal of Pharmacology and Experimental Therapeutics August 1996, 278 (2) 741-746;
  3. Talmaciu, R K

    1. You have access
      Differential effects of muscarinic receptor agonists and phorbol ester on muscarinic and D2-dopamine release-modulatory receptors.
      I S Hoffmann, R K Talmaciu, R Aquino and L X Cubeddu
      Journal of Pharmacology and Experimental Therapeutics August 1996, 278 (2) 662-668;
  4. Tam, Y K

    1. You have access
      Mechanisms of nonlinear pharmacokinetics of mibefradil in chronically instrumented dogs.
      A Skerjanec, S Tawfik and Y K Tam
      Journal of Pharmacology and Experimental Therapeutics August 1996, 278 (2) 817-825;
  5. Tamao, Y

    1. You have access
      Effects of a thrombin inhibitor, argatroban, on ischemic brain damage in the rat distal middle cerebral artery occlusion model.
      H Kawai, S Yuki, J Sugimoto and Y Tamao
      Journal of Pharmacology and Experimental Therapeutics August 1996, 278 (2) 780-785;
  6. Tan, W

    1. You have access
      Pharmacokinetics and tissue disposition of a chimeric oligodeoxynucleoside phosphorothioate in rats after intravenous administration.
      R Zhang, R P Iyer, D Yu, W Tan, X Zhang, Z Lu, H Zhao and S Agrawal
      Journal of Pharmacology and Experimental Therapeutics August 1996, 278 (2) 971-979;
  7. Tanaka, H

    1. You have access
      Use of chloride blockers: a novel approach for cardioprotection against ischemia-reperfusion damage.
      H Tanaka, S Matsui, T Kawanishi and K Shigenobu
      Journal of Pharmacology and Experimental Therapeutics August 1996, 278 (2) 854-861;
  8. Tannu, S A

    1. You have access
      Pharmacological evidence for tumor necrosis factor as a mediator of allergic inflammation in the airways.
      L M Renzetti, P M Paciorek, S A Tannu, N C Rinaldi, J E Tocker, M A Wasserman and P R Gater
      Journal of Pharmacology and Experimental Therapeutics August 1996, 278 (2) 847-853;
  9. Tawfik, S

    1. You have access
      Mechanisms of nonlinear pharmacokinetics of mibefradil in chronically instrumented dogs.
      A Skerjanec, S Tawfik and Y K Tam
      Journal of Pharmacology and Experimental Therapeutics August 1996, 278 (2) 817-825;
  10. Terasaki, T

    1. You have access
      Comparative distribution of quinolone antibiotics in cerebrospinal fluid and brain in rats and dogs.
      T Ooie, H Suzuki, T Terasaki and Y Sugiyama
      Journal of Pharmacology and Experimental Therapeutics August 1996, 278 (2) 590-596;
  11. Thompson, A C

    1. You have access
      Role of extracellular dopamine in the initiation and long-term expression of behavioral sensitization to cocaine.
      C A Heidbreder, A C Thompson and T S Shippenberg
      Journal of Pharmacology and Experimental Therapeutics August 1996, 278 (2) 490-502;
  12. Tocker, J E

    1. You have access
      Pharmacological evidence for tumor necrosis factor as a mediator of allergic inflammation in the airways.
      L M Renzetti, P M Paciorek, S A Tannu, N C Rinaldi, J E Tocker, M A Wasserman and P R Gater
      Journal of Pharmacology and Experimental Therapeutics August 1996, 278 (2) 847-853;
  13. Tokuno, T

    1. You have access
      Effects of ONO-1101, a novel beta-antagonist, on action potential and membrane currents in cardiac muscle.
      K Muraki, H Nakagawa, N Nagano, S Henmi, H Kawasumi, T Nakanishi, K Imaizumi, T Tokuno, K Atsuki, Y Imaizumi and M Watanabe
      Journal of Pharmacology and Experimental Therapeutics August 1996, 278 (2) 555-563;
  14. Trendelenburg, A U

    1. You have access
      The presynaptic alpha-2 autoreceptors in pig brain cortex are alpha-2A.
      A U Trendelenburg, N Limberger and K Starke
      Journal of Pharmacology and Experimental Therapeutics August 1996, 278 (2) 462-467;
  15. Trok, K

    1. You have access
      A comparison of the effects of glial cell line-derived neurotrophic factor on spinal cord and cortex cerebri grafts.
      K Trok, S Almström and L Olson
      Journal of Pharmacology and Experimental Therapeutics August 1996, 278 (2) 941-949;
  16. Tuck, M L

    1. You have access
      Platelet lipoxygenase inhibitors attenuate thrombin- and thromboxane mimetic-induced intracellular calcium mobilization and platelet aggregation.
      M D Nyby, M Sasaki, Y Ideguchi, H E Wynne, M T Hori, M E Berger, M S Golub, A S Brickman and M L Tuck
      Journal of Pharmacology and Experimental Therapeutics August 1996, 278 (2) 503-509;

U

  1. Undem, B J

    1. You have access
      Inhibition by zinc protoporphyrin-IX of vasoactive intestinal peptide-induced relaxations of guinea pig isolated trachea.
      B J Undem, J L Ellis, S Meeker, A Fischer and B J Canning
      Journal of Pharmacology and Experimental Therapeutics August 1996, 278 (2) 964-970;
  2. Urrutia, A

    1. You have access
      Cloning and functional characterization of human heteromeric N-methyl-D-aspartate receptors.
      S D Hess, L P Daggett, J Crona, C Deal, C C Lu, A Urrutia, L Chavez-Noriega, S B Ellis, E C Johnson and G Veliçelebi
      Journal of Pharmacology and Experimental Therapeutics August 1996, 278 (2) 808-816;

V

  1. Valentine, J L

    1. You have access
      Antiphencyclidine monoclonal Fab fragments reverse phencyclidine-induced behavioral effects and ataxia in rats.
      J L Valentine, M Mayersohn, W D Wessinger, L W Arnold and S M Owens
      Journal of Pharmacology and Experimental Therapeutics August 1996, 278 (2) 709-716;
    2. You have access
      Antiphencyclidine monoclonal antibody therapy significantly changes phencyclidine concentrations in brain and other tissues in rats.
      J L Valentine and S M Owens
      Journal of Pharmacology and Experimental Therapeutics August 1996, 278 (2) 717-724;
  2. van der Staay, F J

    1. You have access
      Effects of metrifonate, its transformation product dichlorvos, and other organophosphorus and reference cholinesterase inhibitors on Morris water escape behavior in young-adult rats.
      F J van der Staay, V C Hinz and B H Schmidt
      Journal of Pharmacology and Experimental Therapeutics August 1996, 278 (2) 697-708;
  3. Vassalle, M

    1. You have access
      Ca(++)-dependence of caffeine modulation of the rate-force relation in canine cardiac Purkinje fibers.
      H Satoh and M Vassalle
      Journal of Pharmacology and Experimental Therapeutics August 1996, 278 (2) 826-835;
  4. Veasey, S C

    1. You have access
      WAY-100635, a potent and selective 5-hydroxytryptamine1A antagonist, increases serotonergic neuronal activity in behaving cats: comparison with (S)-WAY-100135.
      C A Fornal, C W Metzler, R A Gallegos, S C Veasey, A C McCreary and B L Jacobs
      Journal of Pharmacology and Experimental Therapeutics August 1996, 278 (2) 752-762;
  5. Veliçelebi, G

    1. You have access
      Cloning and functional characterization of human heteromeric N-methyl-D-aspartate receptors.
      S D Hess, L P Daggett, J Crona, C Deal, C C Lu, A Urrutia, L Chavez-Noriega, S B Ellis, E C Johnson and G Veliçelebi
      Journal of Pharmacology and Experimental Therapeutics August 1996, 278 (2) 808-816;
  6. Villalobos, A R

    1. You have access
      Mechanism mediating basolateral transport of 2,4-dichlorophenoxyacetic acid in rat kidney.
      A R Villalobos, C A Dunnick and J B Pritchard
      Journal of Pharmacology and Experimental Therapeutics August 1996, 278 (2) 582-589;

W

  1. Wagstaff, J D

    1. You have access
      Microdialysis assessment of methamphetamine-induced changes in extracellular neurotensin in the striatum and nucleus accumbens.
      J D Wagstaff, J W Gibb and G R Hanson
      Journal of Pharmacology and Experimental Therapeutics August 1996, 278 (2) 547-554;
  2. Walsh, S L

    1. You have access
      Buprenorphine, morphine and naloxone effects during ascending morphine maintenance in humans.
      K J Schuh, S L Walsh, G E Bigelow, K L Preston and M L Stitzer
      Journal of Pharmacology and Experimental Therapeutics August 1996, 278 (2) 836-846;
  3. Wang, G F

    1. You have access
      Vascular hyporesponsiveness in aorta from portal hypertensive rats: possible sites of involvement.
      Y T Huang, G F Wang, M C Yang, S P Chang, H C Lin and C Y Hong
      Journal of Pharmacology and Experimental Therapeutics August 1996, 278 (2) 535-541;
  4. Wang, H

    1. You have access
      Chloramphenicol and the inflammatory response in the rat. Upregulation of the gene for T2-kininogen in liver.
      P Raymond, H Wang, C Blais, A Décarie, A Adam and R Morais
      Journal of Pharmacology and Experimental Therapeutics August 1996, 278 (2) 934-940;
  5. Washburn, M S

    1. You have access
      Block of alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptors by polyamines and polyamine toxins.
      M S Washburn and R Dingledine
      Journal of Pharmacology and Experimental Therapeutics August 1996, 278 (2) 669-678;
  6. Wasserman, M A

    1. You have access
      Pharmacological evidence for tumor necrosis factor as a mediator of allergic inflammation in the airways.
      L M Renzetti, P M Paciorek, S A Tannu, N C Rinaldi, J E Tocker, M A Wasserman and P R Gater
      Journal of Pharmacology and Experimental Therapeutics August 1996, 278 (2) 847-853;
  7. Watanabe, M

    1. You have access
      Effects of ONO-1101, a novel beta-antagonist, on action potential and membrane currents in cardiac muscle.
      K Muraki, H Nakagawa, N Nagano, S Henmi, H Kawasumi, T Nakanishi, K Imaizumi, T Tokuno, K Atsuki, Y Imaizumi and M Watanabe
      Journal of Pharmacology and Experimental Therapeutics August 1996, 278 (2) 555-563;
  8. Watkins, L R

    1. You have access
      Morphine-induced alterations in antibody levels: receptor and immune mechanisms.
      L L Lockwood, L H Silbert, M R Fleshner, C McNeal, L R Watkins, M L Laudenslager, K C Rice, R J Weber and S F Maier
      Journal of Pharmacology and Experimental Therapeutics August 1996, 278 (2) 689-696;
  9. Weber, R J

    1. You have access
      Morphine-induced alterations in antibody levels: receptor and immune mechanisms.
      L L Lockwood, L H Silbert, M R Fleshner, C McNeal, L R Watkins, M L Laudenslager, K C Rice, R J Weber and S F Maier
      Journal of Pharmacology and Experimental Therapeutics August 1996, 278 (2) 689-696;
  10. Wessinger, W D

    1. You have access
      Antiphencyclidine monoclonal Fab fragments reverse phencyclidine-induced behavioral effects and ataxia in rats.
      J L Valentine, M Mayersohn, W D Wessinger, L W Arnold and S M Owens
      Journal of Pharmacology and Experimental Therapeutics August 1996, 278 (2) 709-716;
  11. Wilmot, C A

    1. You have access
      Ex vivo studies with iloperidone (HP 873), a potential atypical antipsychotic with dopamine D2/5-hydroxytryptamine2 receptor antagonist activity.
      A M Szczepanik, L R Brougham, J E Roehr, P G Conway, D B Ellis and C A Wilmot
      Journal of Pharmacology and Experimental Therapeutics August 1996, 278 (2) 913-920;
  12. Wong, P Y

    1. You have access
      Leukotriene B4 modulates in vivo expression of delayed-type hypersensitivity by a receptor-mediated mechanism: regulation by lipoxin A4.
      Z Feng, H P Godfrey, S Mandy, S Strudwick, K T Lin, E Heilman and P Y Wong
      Journal of Pharmacology and Experimental Therapeutics August 1996, 278 (2) 950-956;
  13. Wynne, H E

    1. You have access
      Platelet lipoxygenase inhibitors attenuate thrombin- and thromboxane mimetic-induced intracellular calcium mobilization and platelet aggregation.
      M D Nyby, M Sasaki, Y Ideguchi, H E Wynne, M T Hori, M E Berger, M S Golub, A S Brickman and M L Tuck
      Journal of Pharmacology and Experimental Therapeutics August 1996, 278 (2) 503-509;

Y

  1. Yamada, T

    1. You have access
      The endothelin receptor is a major determinant for the nonlinear tissue distribution of the endothelin antagonist BQ-123.
      H C Shin, Y Kato, Y Shitara, T Yamada, T Nakamura, A Hisaka and Y Sugiyama
      Journal of Pharmacology and Experimental Therapeutics August 1996, 278 (2) 607-613;
  2. Yamashita, N

    1. You have access
      A nitric oxide donor reverses myocardial injury in rabbits with acute hypercholesterolemia.
      S Hoshida, N Yamashita, J Igarashi, M Nishida, M Hori, T Kuzuya and M Tada
      Journal of Pharmacology and Experimental Therapeutics August 1996, 278 (2) 741-746;
  3. Yang, M C

    1. You have access
      Vascular hyporesponsiveness in aorta from portal hypertensive rats: possible sites of involvement.
      Y T Huang, G F Wang, M C Yang, S P Chang, H C Lin and C Y Hong
      Journal of Pharmacology and Experimental Therapeutics August 1996, 278 (2) 535-541;
  4. Yano, M

    1. You have access
      Carrier-mediated active transport of BQ-123, a peptidic endothelin antagonist, into rat hepatocytes.
      T Nakamura, A Hisaka, Y Sawasaki, Y Suzuki, T Fukami, K Ishikawa, M Yano and Y Sugiyama
      Journal of Pharmacology and Experimental Therapeutics August 1996, 278 (2) 564-572;
  5. Yu, D

    1. You have access
      Pharmacokinetics and tissue disposition of a chimeric oligodeoxynucleoside phosphorothioate in rats after intravenous administration.
      R Zhang, R P Iyer, D Yu, W Tan, X Zhang, Z Lu, H Zhao and S Agrawal
      Journal of Pharmacology and Experimental Therapeutics August 1996, 278 (2) 971-979;
  6. Yuki, S

    1. You have access
      Effects of a thrombin inhibitor, argatroban, on ischemic brain damage in the rat distal middle cerebral artery occlusion model.
      H Kawai, S Yuki, J Sugimoto and Y Tamao
      Journal of Pharmacology and Experimental Therapeutics August 1996, 278 (2) 780-785;

Z

  1. Zamir, N

    1. You have access
      Thrombin stimulates atrial natriuretic peptide secretion from rat cardiac atrium.
      L Klapper, S Nachshon, O Zamir and N Zamir
      Journal of Pharmacology and Experimental Therapeutics August 1996, 278 (2) 476-481;
  2. Zamir, O

    1. You have access
      Thrombin stimulates atrial natriuretic peptide secretion from rat cardiac atrium.
      L Klapper, S Nachshon, O Zamir and N Zamir
      Journal of Pharmacology and Experimental Therapeutics August 1996, 278 (2) 476-481;
  3. Zarzuelo, A

    1. You have access
      Effect of quercitrin on acute and chronic experimental colitis in the rat.
      F Sánchez de Medina, J Gálvez, J A Romero and A Zarzuelo
      Journal of Pharmacology and Experimental Therapeutics August 1996, 278 (2) 771-779;
  4. Zhang, R

    1. You have access
      Pharmacokinetics and tissue disposition of a chimeric oligodeoxynucleoside phosphorothioate in rats after intravenous administration.
      R Zhang, R P Iyer, D Yu, W Tan, X Zhang, Z Lu, H Zhao and S Agrawal
      Journal of Pharmacology and Experimental Therapeutics August 1996, 278 (2) 971-979;
  5. Zhang, X

    1. You have access
      Pharmacokinetics and tissue disposition of a chimeric oligodeoxynucleoside phosphorothioate in rats after intravenous administration.
      R Zhang, R P Iyer, D Yu, W Tan, X Zhang, Z Lu, H Zhao and S Agrawal
      Journal of Pharmacology and Experimental Therapeutics August 1996, 278 (2) 971-979;
  6. Zhao, H

    1. You have access
      Pharmacokinetics and tissue disposition of a chimeric oligodeoxynucleoside phosphorothioate in rats after intravenous administration.
      R Zhang, R P Iyer, D Yu, W Tan, X Zhang, Z Lu, H Zhao and S Agrawal
      Journal of Pharmacology and Experimental Therapeutics August 1996, 278 (2) 971-979;
  7. Zhou, Q

    1. You have access
      Pharmacologic characteristics of potentiation of 5-HT3 receptors by alcohols and diethyl ether in NCB-20 neuroblastoma cells.
      Q Zhou and D M Lovinger
      Journal of Pharmacology and Experimental Therapeutics August 1996, 278 (2) 732-740;
Back to top
PreviousNext

In this issue

Journal of Pharmacology and Experimental Therapeutics
Vol. 278, Issue 2
1 Aug 1996
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
  • Back Matter (PDF)
  • Editorial Board (PDF)
  • Front Matter (PDF)
Sign up for alerts
  • Most Cited
  • Most Read
Loading
  • Interindividual variations in human liver cytochrome P-450 enzymes involved in the oxidation of drugs, carcinogens and toxic chemicals: studies with liver microsomes of 30 Japanese and 30 Caucasians.
  • Functional Selectivity and Classical Concepts of Quantitative Pharmacology
  • Abl Protein-Tyrosine Kinase Inhibitor STI571 Inhibits In Vitro Signal Transduction Mediated by c-Kit and Platelet-Derived Growth Factor Receptors
  • The Prediction of Human Pharmacokinetic Parameters from Preclinical and In Vitro Metabolism Data
  • A METHOD FOR DETERMINING LOSS OF PAIN SENSATION
More...
Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About JPET
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Drug Metabolism and Disposition
  • Molecular Pharmacology
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-0103 (Online)

Copyright © 2023 by the American Society for Pharmacology and Experimental Therapeutics